EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing no session group Posters View

Rapid response to Baricitinib in patients with rheumatoid arthritis and an inadequate response to methotrexate and at least one biologic (blank) (blank) DMARD: a clinical and power Doppler ultrasound study. Clinical features and the course of COVID-19 in patients with Familial Mediterranean Fever

KZR-616, A Selective Immunoproteasome Inhibitor for the Treatment of Systemic Lupus Erythematosus: Results from the Completed Dose Escalation Phase 1b Portion of the MISSION Study Are smoking and alcohol associated with peripheral musculoskeletal involvement in patients with Spondyloarthritis? Results from the ASAS-PerSpA study.

Histopathological analysis of lupus nephritis incorporating BANFF criteria emphasizes the importance of tubulointerstitial changes for creatinine and proteinuria at 12 months after renal biopsy

EFFICACY AND SAFETY OF : RESULTS FROM THE PHASE III RANDOMIZED CONTROLLED TRIAL IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS INADEQUATELY CONTROLLED BY TNF INHIBITOR THERAPY

Effect of tofacitinib on spinal vertebral body and posterolateral element inflammation and structural lesions using the Canada-Denmark MRI scoring system in patients with ankylosing spondylitis: results from a Phase 2 study Long term safety and tolerability with etanercept biosimilar (YLB113), results from a 2‑year Open Label Extension study (Study No. YLB113-003) Post Covid arthritis; Reactive arthritis or Rheumatic disease Flare or Both 18F-fluorodeoxyglucose Positron Emission Tomography as a Predictor of Angiographic Progression of Disease in Large-Vessel Vasculitis Knee joint distraction results in MRI cartilage thickness increase up to ten years after treatment Next-generation online telemedicine system utilizing mixed reality for rheumatoid arthritis Impact of the COVID-19 pandemic on morbidity and mortality among Swedish patients with inflammatory joint diseases versus the general population

Long-term treatment with in patients with axial spondyloarthritis: Two-year results from COAST-Y

HOW DOES GENDER AFFECT TREATMENT OUTCOMES AND RETENTION RATES IN PATIENTS WITH ANKYLOSING SPONDYLITIS? - REAL WORLD DATA FROM THE GERMAN AQUILA STUDY

Senescence did not alter the chondroprotective effect of extracellular vesicles from mesenchymal stromal cells

Lifestyle habits in patients with rheumatoid arthritis – a cross sectional study on two Scandinavian cohorts Ixekizumab efficacy on spinal pain, disease activity and quality of life in patients with psoriatic arthritis presenting with symptoms suggestive of axial involvement PROMIS Assessment of Response to Treatment with IV or in Rheumatoid Arthritis Patients: Results from the Phase-4 AWARE Study Does Sildenafil Improve Endothelial Dysfunction in Rheumatoid Arthritis? – A Pilot Clinical Trial Novel Long non-coding RNA expression profile of peripheral blood monouclear cell revealed potential biomarkers and regulatory mechanism in Systemic Lupus Erythematosus

Pro-inflammatory effects of human apatite crystals extracted from patients suffering from calcific tendinopathy

Are antimalarials safe for the heart of patients with systemic lupus erythematosus? Analysis of factors associated with the development of heart failure in patients in the Spanish Society of Rheumatology Lupus Registry (RELESSER) The Musculoskeletal System Manifestations in Children with Familial Mediterranean Fever Liraglutide has potent anti-inflammatory and anti-catabolic in vitro activities in osteoarthritis. Identifying Meaningful Change in the RA Flare Questionnaire Scores in Rheumatoid Arthritis Development of a risk prediction model for venous thromboembolism in patients with systemic lupus erythematosus: The SLE-VTE score

Role of intraarticular biologics and methotrexate in the management of active inflammatory monoarthritis. Determining in which preclinical stage HLA-shared epitope alleles and smoking exert their effect in the development of rheumatoid arthritis

Metabolic Changes Induced by Anti-Malondialdehyde/Malindialdehyde-Acetaldehyde Antibodies Promote Osteoclast Development

Predictors of Change in Disease Activity in Rheumatoid Arthritis after Start of Treatment with Abatacept

Willingness To Get The COVID-19 Vaccine Among Patients With Rheumatic Diseases, Health Workers and General Population BARRIERS AND FACILITATORS OF A NEW MODEL OF STRATIFIED EXERCISE THERAPY IN KNEE OSTEOARTHRITIS: A QUALITATIVE STUDY EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) Risk factors of low bone mineral density in women with systemic sclerosis Reduction of Anterior Uveitis Flares in Patients with Axial Spondyloarthritis During Treatment: 96-Week Results from the C-VIEW Study PERFUSE: A French Prospective/Retrospective Noninterventional Cohort Study of Infliximab-Naïve and Transitioned Patients Receiving Infliximab Biosimilar SB2; 12-month Analysis

Tocilizumab decreases angiogenesis in Rheumatoid Arthritis through its regulatory effect on EMMPRIN/CD147 Nurse led remote management of osteoporosis – do patients approve? NCOA3 amplifies profibrotic transcriptional programs in Systemic Sclerosis Sequence complementarity between SARS-CoV-2 genome and human noncoding RNAs associated with immunological disorders: an in silico pivotal study.

Knee and hip osteoarthritis are associated with subclinical and manifest atherosclerosis: a systematic review and meta-analysis

Patients' safety skills assessment with biologics and JAK inhibitors: update of the BioSecure questionnaire Effect of socio-economic status and educational level on COVID-19 outcomes in patients with rheumatic diseases from Argentina: Data from the SAR-COVID Registry Trajectories of Glucocorticoid-Therapy in Early Rheumatoid Arthritis: First Results of a Scoping Systematic Review and Meta-Analysis of Observational Cohort Studies Pulmonary artery pseudoaneurysms in Behcet’s Disease Treatment compliance of patients with rheumatoid arthritis during the first wave of the SARS-CoV-2/COVID-19 pandemic in Portugal: results from the COVID in RA (COVIDRA) survey.

Ultrasound assessment of gout lesions in an Algerian population with asymptomatic hyperuricemia Diagnostic accuracy of Conventional Radiography of the knee for Calcium Pyrophosphate Deposition Disease: an ancillary study of the OMERACT Ultrasound – CPPD group Improvements in patient-reported impact of psoriatic arthritis with IL-12/23 () or tumour necrosis factor inhibitors: 1-year data from the large, real-world PsABio study Differences in range of motion and mechanical muscle characteristics among inflammatory and mechanical spinal pain: a case-control study. A negative interferon biomarker CD169 / SIGLEC-1 rules out systemic lupus erythematosus

Clinical and immunological characteristics of patients with juvenile-, adult- and late-onset systemic lupus erythematosus Are biologic and targeted synthetic DMARDs safe to use in patients with renal impairment?

Efficacy of Subcutaneous Tanezumab for the Treatment of Osteoarthritis of the Knee or Hip: A Post-hoc Subgroup Analysis of Patients from a Randomized, NSAID-Controlled Study with a History of Depression, Anxiety, or Insomnia The impact of cardiovascular comorbidities on knee osteoarthritis progression

Post-traumatic stress disorder and quality of life in systemic lupus erythematosus. A cross sectional web survey-based study. Predictors of Response in Patients with Non-Radiographic Axial Spondyloarthritis Receiving Certolizumab Pegol in the C-axSpAnd Study Subchondral bone normalization after knee joint distraction treatment as measured with CT

The OMERACT Knee Inflammation MRI Scoring System: Validation of Quantitative Methodologies and Tri-compartmental Overlays by Comparison with the MRI Osteoarthritis Knee Score

A Longitudinal Study of Sarcopenia, Locomotive Syndrome, and Frailty in Patients with Rheumatoid Arthritis: from the CHIKARA study

The utility of ultrasound to predict patient outcomes in shoulder pain: a prospective observational study of 500 patients

The application of MTX-loading DNA tetrahedron in treating Collagen-induced arthritis mice via regulating macrophage Effects of tofacitinib therapy on arginine and methionine metabolites in association with vascular pathophysiology in rheumatoid arthritis: a metabolomic approach Similar Clinical Responses Achieved with Lower Versus Standard Doses of Infliximab Biosimilar CT-P13 in Patients with Ankylosing Spondylitis: Real-world Results from the RAAS Study

Safety and Efficacy of Biologics in Elderly Patients with Rheumatoid Arthritis in a Real World Study: Use of Intravenous Golimumab and Infliximab in Adults with Rheumatoid Arthritis ≥65 Years of Age

Bimekizumab Safety and Efficacy in Patients with Psoriatic Arthritis: 3-Year Results from a Phase 2b Open-Label Extension Study Incidence Rates of Difficult-to-treat Rheumatoid Arthritis in Real-world Clinical Practice

CHEMOPROPHYLAXIS IN LATENT TUBERCULOSIS ASSOCIATED WITH RHEUMATIC IMMUNE-MEDIATED DISEASES. STUDY OF 240 PATIENTS FROM A SINGLE UNIVERSITY HOSPITAL

Prevalence of Hypophosphatasia in Adult Rheumatology Patients Screened by Low Levels of Alkaline Phosphatase

BELIMUMAB ADD-ON THERAPY MOBILISES MEMORY B CELLS INTO THE CIRCULATION OF PATIENTS WITH SLE EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) Chaperone-mediated Autophagy is a Hallmark of Joint Disease in Osteoarthritic Patients

THE EFFECT OF RITUXIMAB BIOSIMILAR THERAPY ON THE EXPRESSION OF INTERFERON-STIMULATED GENES ("INTERFERON SIGNATURE") IN PATIENTS WITH RHEUMATOID ARTHRITIS Safety and Efficacy of Combining Methotrexate and Leflunomide among patients with Inflammatory Arthropathies: Findings from the PRIME registry Effect of Anti-Ro/SSA antibodies for treatment response to methotrexate in rheumatoid arthritis: a retrospective multicenter observational study Telemedicine consultations in rheumatology: identified problems of new technology. Disease Activity and Patients-Reported Outcomes After Switching Between IL-6 Receptor Inhibitors and JAK Inhibitors: An Analysis from the Corrona Registry Adverse Outcomes and Rehospitalization after Delivery Among Women with Systemic Lupus Erythematosus or Rheumatoid Arthritis and Their Infants COVID-19 in patients with rheumatic diseases: Comparison of data from the Argentine registry (SAR-COVID), with the Latin American and Global registry (Global Rheumatology Alliance). Novel Stringent Outcome Measures Applied to the Phase 2 and 3 Trials Pregnancy course in a cohort of women with myositis - Results from RevNatus Juvenile systemic sclerosis (jSSc) patients with overlap characteristics do not have mild disease. Results from the jSSc inception cohort. www.juvenile-scleroderma.com IMPLEMENTATION OF TELEMEDICINE IN RHEUMATOLOGY: VIRTUAL CONSULTATION AS A TOOL FOR DIRECT COMMUNICATION WITH PRIMARY CARE. Bone mineral density, lean and fat mass in postmenopausal women with rheumatoid arthritis

Sustainability of ixekizumab response at the individual patient level over time in radiographic axial spondyloarthritis Effect of Secukinumab versus on ACR Core Components and Health-Related Quality of Life in Patients with Psoriatic Arthritis: Results From the EXCEED Study Factors associated with subclinical atherosclerosis in patients with rheumatoid arthritis.

Behavior and feelings of patients with systemic lupus erythematosus during lockdown measures for the COVID-19 outbreak REVAMPING BIOLOGIC THERAPY DURING COVID-19

Pharmacokinetics and Serum Urate Lowering Effects of AR882, a Novel, Potent and Selective Uricosuric Agent, in Patients with Gout AUTOIMMUNE SYSTEMIC DISEASES AND COVID-19 INFECTION CD21-/low B-cells are increased in patients with ankylosing spondylitis A deep learning method uncovers novel pathway associations in systemic lupus erythematosus

Validation of the Disease Activity Index for Psoriatic Arthritis (DAPSA) with a quick quantitative C-reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis (PsA): A prospective, national, multicenter study.

Anthropometric measurements in upper extremity rehabilitation of patients with rheumatic diseases Is enthesitis a sonographic biomarker of disease severity in psoriatic arthritis? The link between ultrasound entheseal abnormalities and peripheral joint erosive damage.

Large joint disease in rheumatoid arthritis and the role of rheumatoid factor. Results from the Early Rheumatoid Arthritis Study.

Effectiveness of screening in patients with rheumatic disease on biological therapy and risk of active tuberculosis.

Patients with immune mediated inflammatory diseases are overrepresented in low- frequency viral symptom clusters CCN1: An angiogenic actor implicated in the structural damages of rheumatoid arthritis Baseline vitamin D levels and disease activity and response in Portuguese patients with psoriatic arthritis under bMDARD: does it make a difference? Depression, Anxiety and Stress among outpatients with Rheumatoid Arthritis followed up at a Tertiary Care Hospital in Sri Lanka; a Cross-Sectional Study NETAKIMAB REDUCES PSORIATIC ARTHRITIS ACTIVITY IN PATIENTS WITH OR WITHOUT AXIAL DISEASE: SUBANALYSIS OF THE PATERA STUDY Effects of Anifrolumab on Renal Disease in Patients With SLE

HOW DOES GENDER AFFECT SECUKINUMAB TREATMENT OUTCOMES AND RETENTION RATES IN PATIENTS WITH PSORIATIC ARTHRITIS? – REAL WORLD DATA FROM THE GERMAN AQUILA STUDY

New faces of polyarteritis nodosa: 18F-fluorodeoxyglucose Positron Emission Tomography findings in a series of 10 patients.

Genetic susceptibility variants for Rheumatoid Arthritis are not associated with early remission; a multi-cohort study

Serum fetuin-A and visfatin levels in women with rheumatoid arthritis depending on disease activity

Outcomes of COVID-19 Infection among Children and Young People with Pre-existing Rheumatic and Musculoskeletal Diseases. Unveiling axial involvement in psoriatic arthritis: an ancillary analysis of the ASAS-perSpA study. EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start

Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) Insulin resistance and leptin levels in systemic lupus erythematosus patients without diabetes mellitus or fasting hyperglycemia

Expansion of CD4+/CD8+ double-positive T cells is associated with a severe disease course in rheumatoid arthritis Vasculitis in patients with sarcoidosis: a single-institution case series of 17 patients Abnormal electrochemical skin conductance values in patients with AA amyloidosis

Are there clues for the screening of spondyloarthritis in patients with inflammatory bowel diseases? Real world effectiveness of baricitinib in the Swiss rheumatoid arthritis register (SCQM-RA)

Sexual experience in male patients with ankylosing spondylitis: results from a cross-sectional study of 113 patients Voclosporin for Lupus Nephritis: Interim Analysis of the AURORA 2 Extension Study BIIB059 Demonstrated a Consistent Therapeutic Effect on SRI-4 Response Across Subgroups of Participants With Systemic Lupus Erythematosus in the LILAC Phase 2 Study

Synovitis is factor of osteoarthritis knee progression in patients with less than 5 years of disease duration GENDER DIFFERENCES IN THROMBOTIC PRIMARY ANTIPHOSPHOLIPID SYNDROME IN A LARGE COHORT OF PATIENTS FROM FOUR EUROPEAN CENTERS Prevalence of bronchiectasis in rheumatoid arthritis: A systematic review and meta-analysis

MULTICENTER STUDY OF 71 PATIENTS WITH REFRACTORY UVEITIS RELATED TO IMMUNE-MEDIATED INFLAMMATORY DISEASES ON CERTOLIZUMAB PEGOL TREATMENT

Diagnostic value of muscle strength tests for the diagnosis of sarcopenia in rheumatoid arthritis patients A randomised dose ranging, placebo-controlled, Phase II study assessing the efficacy and safety of BI 655064, an antagonistic anti- CD40 antibody, in patients with lupus nephritis Aberrant spliceosome and altered expression of IFN-response related genes are hallmarks of monocytes from lupus patients with renal disease Predictors of toxicity with Hydroxychloroquine and Chloroquine use: a Systematic Review Characteristics and 6-Month Outcomes Among Real-world Patients with Rheumatoid Arthritis Initiating Upadacitinib: Analysis from the Corrona Registry

CARDIAC ADVERSE EFFECTS OF LONG-TERM USE OF HYDROXYCHLOROQUINE IN SYSTEMIC LUPUS ERYTHEMATOSUS. SINGLE UNIVERSITY CENTER STUDY OF 109 PATIENTS Reliability of Conventional Radiography of the knee for the assessment of chondrocalcinosis: an ancillary study of the OMERACT Ultrasound – CPPD group

HORMONES OF ADIPOSE TISSUE IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO HAVE REDUCED BODY WEIGHT

Epione Application: An integrated genotype analysis web server for clinical genomics in Systemic lupus erythematosus (SLE) Segmented Short-Format Online Education Significantly Increases Prediction, Prognosis, and Management of Fibrosing Interstitial Lung Disease Associated with Connective Tissue Disease Clinical Associations of Cognitive Dysfunction in Systemic Lupus Erythematosus (SLE)

Validation of the SIMPLE index for disease activity of systemic lupus erythematosus in Chinese patients Outcomes of surgically resected thoracic aortitis: results from a prospective multi-centre registry Molecular profiling of the remission state in Psoriatic Arthritis: is the fire extinguished? CIRCULATING ENDOTHELIAL CELLS AS A MARKER OF CARDIOVASCULAR DISEASES IN PATIENTS WITH PSORIATIC ARTHRITIS

Anti-TNF Glucocorticoid Receptor Modulator Antibody Drug Conjugate for the Treatment of Autoimmune Diseases Digital rheumatology in the era of COVID-19: Results of a national patient and physician survey FOR THE TREATMENT OF IMMUNE-RELATED ADVERSE EVENTS TO IMMUNE CHECKPOINT INHIBITORS: A CASE SERIES

Identifying high-cost drugs for rare rheumatic diseases in routinely collected NHS data. Results from a pilot study of rituximab use in vasculitis using data from the National Disease Registration Service and the Registration of Complex Rare Diseases-exemplars in Rheumatology (RECORDER) project Clinical manifestations, treatment, and outcomes of “non-criteria” antiphospholipid syndrome in comparison with definite antiphospholipid syndrome: A systematic review and meta-analysis

Can a specialist nurse lead a comprehensive osteoporosis service with remote supervision – an innovative concept Description of sacroiliac CT findings in patients with ankylosing spondylitis aged over 50 years: preliminary results of the CASIAGE study FIBROMYALGIA IN MEXICAN PATIENTS WITH RHEUMATOID ARTHRITIS Determination of the Reliability and Validity of the BETY-Biopsychosocial Questionnaire in Patients with a Diagnosis of Psoriatic Arthritis Patients at risk for RA show the same amount of acute soluble cartilage degradation markers after physical activity compared to patients with established RA EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start

Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) The Incidence and Prevalence of Cardiovascular Diseases in Gout: A Systematic Review and Meta-analysis

Cardiac biomarkers are associated with the development of cardiovascular events in patients with psoriatic arthritis and psoriasis Safety of biologic treatments in solid organ transplant recipients: a systematic review

Air pollution is a predictor of poor response to biological therapies in chronic inflammatory arthritides

Measuring subclinical inflammation in hand and forefoot in patients with arthralgia using 1.5T or 3.0T MRI: does field strength matter?

COVID-19 stress: does it augment pain in people with fibromyalgia and might psychological flexibility protect against this influence?

External Validation of a Multi-biomarker-Based Cardiovascular Disease Risk Prediction Score for Rheumatoid Arthritis Patients ASSESSMENT OF THE ASSOCIATION BETWEEN ESTIMATED CARDIOVASCULAR RISK AND MASEI INDEX IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS Influence of various factors on the immunogenicity of 23-valent polysaccharide pneumococcal vaccine in patients with systemic lupus erythematosus

Prevalent comorbidities associated with clinically diagnosed osteoarthritis: a case-control analysis including 1,936,792 people. Is there an association between autoantibodies induction and loss of therapeutic efficacy in patients with axial spondyloarthritis and psoriatic arthritis treated with anti-TNF-α agents?

Randomized, Controlled, Phase 2 Trial of Type 1 IFN Inhibitor Anifrolumab in Patients with Active Proliferative Lupus Nephritis Risk of ACPA positivity by motif-based classification of HLA-DRB1 shared epitope alleles in RA

The Negative Impact of Undiagnosed Depression in Axial Spondyloarthroparthy: Results of a Screening Study IDENTIFICATION OF PATIENTS AFFECTED WITH ANKYLOSING SPONDYLITIS AND INFLAMMATORY BOWEL DISEASE OVERLAP USING COLLAGEN BIOMARKERS

Food sources of dietary fibre and risk of total knee replacement related to severe osteoarthritis, the Singapore Chinese Health Study RELATIONSHIP BETWEEN FIBRINOGEN TO ALBUMIN RATIO AND DISEASE ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS Exploring Equivalence Between Biosimilar SB4 and Reference Etanercept by Assessing Effectiveness in Rheumatoid Arthritis Patients Treated in Ordinary Clinical Practice Citrullination induces epigenetic memory of the innate immune system

A new risk model is able to identify Systemic Sclerosis patients with a low risk of disease progression Associations between the neovascularization of carotid atherosclerotic plaques, lipid parameters and immunological disorders in patients with rheumatoid arthritis

Optimization of Dual Energy Computed Tomography post-processing to reduce lower limb artifacts in gout. Ianalumab (VAY736) Safety and Efficacy in Patients with Sjogren’s Syndrome: 52 Week Results from a Randomised, Placebo- controlled, Phase 2b Dose-ranging Trial Validation of the Simplified Disease Activity Index (SDAI) with a quick quantitative C-reactive protein assay (SDAI-Q) in patients with rheumatoid arthritis: A national, multicenter study. Treatment of giant cell arteritis with tocilizumab: A retrospective cohort study of 119 patients

The impact of telemedicine and COVID-19 on a tertiary rheumatology service: a retrospective audit Comparison of MBDA Score, Patient Global Assessment and Evaluator Global Assessment for Predicting Risk of Radiographic Progression Expectations and potential concerns of patients with autoimmune and rheumatic diseases regarding vaccination against SARS-CoV-2 (COVID-19): the worldwide online VAXICOV study

Redefining the Clinical and Laboratory Features of Rheumatic Pleural Effusion: A 30-case Series.

Long-term Effectiveness of the Rituximab Half Dose Regimen Following a Response to the Licensed Dose in Rheumatoid Arthritis

QRISK3 Relation to Carotid Plaque is Higher than that of SCORE In Patients with Systemic Lupus Erythematosus Gastrointestinal symptoms and Rheumatic Diseases: two sides of the same coin

Evaluation of a virtual reality-based application to educate healthcare professionals and medical students about inflammatory arthritis Assessing senescent human lymph node stromal cells during rheumatoid arthritis development EFFECTIVENESS AND SAFETY OF COMBINED BIOLOGICAL THERAPY IN PATIENTS WITH REFRACTORY SPONDYLOARTHRITIS Immunogenicity of Rituximab biosimilar GP2013: a rare event, but not without consequences ...

Herpes Zoster In A Multi-ethnic Systemic Lupus Erythematosus (SLE) Cohort : Clinical Features and Risk Factors EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start

In Phase-3 trials DISCOVER 1 & 2, Reduced Fatigue over 52 weeks in Patients with Psoriatic Arthritis and Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) Demonstrated Independent Treatment Effects on Fatigue after Adjustment for Clinical Response (ACR20) Development of a new and simplified formula to predict mortality in patients with ANCA-associated vasculitis admitted to the intensive care unit

Evaluation of the Nonsteroidal Anti-Inflammatory Drug-Sparing Effect of Secukinumab in Patients with Ankylosing Spondylitis: Results of the Multicenter, Randomised, Double-blind, Phase IV ASTRUM-trial ASSOCIATION OF NAIL PSORIASIS WITH WORSE DISEASE OUTCOMES IN PSORIATIC ARTHRITIS PATIENTS. DATA FROM CLINICAL PRACTICE Patients’ perceptions of person-centred care in early RA: A qualitative study

Combination Treatment of AR882, a New URAT1 Inhibitor, and Xanthine Oxidase Inhibitors Allopurinol or Febuxostat: Effect on Uric Acid, Hypoxanthine and Xanthine in Plasma or Serum and Urine The effect of SARS-CoV-2 on the course and the treatment of rheumatic inflammatory diseases. Experience form the northwestern Greece. A tocilizumab dosing strategy in rheumatoid arthritis patients with stable disease aiming to prevent overtreatment and unnecessary costs Clinical course of COVID-19 in children with rheumatic disease under biologic therapy

Sleep disturbance and bone mineral density, risk of falls and fracture: results from a 10.7-year prospective cohort study UVEAL CATARACT IN PATIENTS WITH SPONDYLOARTHRITIS AND OTHER IMMUNO-INFLAMMATORY DISEASES AND ITS SURGICAL TREATMENT The reduction of retinal microvascular alterations and the decrease of a potentially related T-cell subset in patients with active rheumatoid arthritis treated with abatacept. Antibodies to Porphyromonas gingivalis associate with the presence of rheumatoid arthritis-related autoantibodies in patients with periodontitis

Impact of Upadacitinib on Reducing Pain in Patients With Active Psoriatic Arthritis: Results From Two Phase 3 Trials in Patients with Inadequate Response to Non-biologic or Biologic DMARDs

ANALYSIS OF FACTORS ASSOCIATED WITH THE EFFECTIVENESS OF ABATACEPT IN THE ORIGAMI STUDY

Can the SLE-DAS substitute BILAG to measure Lupus disease activity in clinical trials? Post-hoc analysis of the BLISS-76 trial. Risk of malnutrition in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD): further analyses of the SENSCIS trial Guselkumab Provides Sustained Domain-Specific and Comprehensive Efficacy As Assessed Using Composite Endpoints in Patients with Active Psoriatic Arthritis Identification of molecular phenotypes and immune cell infiltration in psoriatic arthritis patients’ skin tissues by integrated bioinformatics analysis

Efficacy and Safety of Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 (TYK2) Inhibitor, Compared With Placebo and Apremilast in Moderate to Severe Plaque Psoriasis: Results From the Phase 3 POETYK PSO-1 Study Anxiety in psoriatic arthritis patients: results from the HUR-BIO biologic registry Echocardiographic findings in Psoriatic Arthritis, Rheumatoid Arthritis and controls Switching of treatment from reference etanercept to Sandoz etanercept biosimilar in patients with rheumatic diseases: an interim analysis of real-world data from the COMPACT study MANAGEMENT OF DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS DURING THE COVID-19 PANDEMIC: EVIDENCE FROM THE ITALIAN EPICENTER Comparative efficacy of combination therapy with biologic or target synthetic drugs for Rheumatoid Arthritis: a Bayesian network meta- analysis.

Evaluating the multivisceral involvement on adult-onset Still's disease to retrieve imaging-based differences in patients with and without macrophage activation syndrome; results from a single-centre observational study

Treatment effectiveness of upadacitinib at 3 months in US patients with rheumatoid arthritis from the United Rheumatology Normalized Integrated Community Evidence (NICE[TM]) real-world data

THE ROLE OF VIRTUAL TELEPHONE VISITS IN THE TIGHT CONTROL OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TARGETED THERAPIES DURING THE COVID-19 PANDEMIC

miRNAs deregulated in response to IL17A inhibitors in psoriatic arthritis regulate gene products in Rho-GTPase pathways

Trends in the Incidence of Giant Cell Arteritis across Seven Decades and Changes in Diagnostic Modalities: a Population-based Study The efficacy, safety and outcome after 5-8 years of parenteral anti-osteoporotic therapy evaluated at a district general hospital in the UK.

Mortality patterns and their prognostic value in patients with systemic lupus erythematosus in Cuba EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start Secukinumab 150 mg Provides Sustained Improvement in Signs and Symptoms of Non-radiographic Axial Spondyloarthritis: 2-year Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) Results From the PREVENT Study

Biologics initiation in moderate vs severe rheumatoid arthritis patients: prospective observational study from a Canadian registry A Multicenter Randomized Study in Rheumatoid Arthritis to Compare Iguratimod, Methotrexate, or Combination: 52 Week Efficacy and Safety Results of the SMILE Trial TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN REAL-WORLD SETTINGS: A NATIONAL MULTICENTER STUDY OF 167 PATIENTS FROM ARGENTINA Characteristics and burden of disease in patients with radiographic versus non-radiographic axial spondyloarthritis in the Ankylosing Spondylitis Registry of Ireland cohort Characterization of PK/PD of Anifrolumab in Patients With Moderate to Severe SLE Evaluation of spinal radiographic progression in patients with radiographic axial spondyloarthritis receiving ixekizumab therapy over 2 years Skin limited IgA vasculitis in adults

Clinical characteristics associated with glandular involvement evaluated by salivary gland ultrasonography in Sjögren's syndrome Genetic variants within psoriatic arthritis (PsA)-weighted genes FBXL19 and HLA-B*39 may serve as a potential link between PsA and obesity

Effect of tofacitinib on patient-reported outcomes in patients with active ankylosing spondylitis: results from a Phase 3 trial

Cluster Analysis and Comparison of Cumulative Damage by DIAPS in a Single Center Cohort of APS Patients

Experience with adalimumab biosimilar use in clinical practice: data from the German BIKER-Registry Impact of lockdown during COVID-19 pandemic on the onset of post-traumatic stress disorder (PTSD) in systemic sclerosis patients: a case-control study A 6-MONTH OPEN-LABEL EXTENSION STUDY OF THE SAFETY AND EFFICACY OF INTRAVENOUS IN PATIENTS WITH LUPUS NEPHRITIS Baricitinib decreases anti-dsDNA and IgG antibodies in adults with systemic lupus erythematosus from a phase 2 double-blind, randomized, placebo-controlled trial How do clinical and socioeconomic factors impact on work disability in early axial spondyloarthritis? Five-year data from the DESIR cohort.

Splenic Extramedullary Hematopoiesis is Omnipresent and Correlates with Disease Severity in the Lupus NZB/W F1 Murine Model Lung ultrasound to assess the severity of interstitial lung disease in systemic sclerosis.

Proteomics Analysis Comparing the Mode of Action of Upadacitinib Between Non-Biologic-DMARD-IR and Biologic-DMARD-IR PsA Patients Identifies Distinct Pathogenic Pathways in the SELECT-PsA 1 and SELECT-PsA 2 Phase 3 Studies Prevalence of Joint Effusion, Hyperperfusion and Enthesitis in Young Healthy Individuals

Decreased risk of osteonecrosis over time in patients with systemic lupus erythematosus using Japanese health insurance database Epidemiologic profile and channeling to treatment in Rheumatoid Arthritis patients treated with Abatacept over the last 5 years: Data from the Spanish register BIOBADASER 3.0

Synovial myeloid-stromal pathotype predicts one-year radiographic progression in active rheumatoid arthritis Shows Sustained Long-Term Improvements in Patient-Reported Outcomes and Quality of Life in Ankylosing Spondylitis: 3-Year Results from a Phase 2b Study Effect of the COVID19 pandemic on rheumatologist prescription behaviour of new advanced therapy: data of the TARDIS-RA registry, a nationwide Belgian Biologic registry Hepatotropic viruses with higher rheumatoid factor, but not rheumatic diseases link to prevalent Cryoglobulinemia. Correlation of clinical and serological markers with etiological causes. ELIGIBILITY FOR ANTI-FIBROTIC TREATMENT WITH NINTEDANIB OF PATIENTS WITH SYSTEMIC SCLEROSIS RELATED INTERSTITIAL LUNG DISEASE

Alcohol and inflammatory arthritis disease activity: perspectives from a 979-patient cohort with systematic review and meta-analysis

Identification of Common Functional Pathways in Patients with Lupus and COVID-19 by Time-series Analysis

Damage progression of finger joint cartilage evaluated by ultrasound and X-ray in patients with rheumatoid arthritis (RA)

Mortality and its related factors in patients with IgG4-related disease: A Japanese single-center study

The association of clinical and structural knee osteoarthritis with physical activity in the middle-aged population: The NEO study

Medical costs for patients starting treatment for rheumatoid arthritis who have comorbid diabetes mellitus in Japan

EFFECTIVENESS AND SAFETY OF SECUKINUMAB IN NAïVE OR TNF-INHIBITORS FAILURE AXIAL SPONDYLOARTHRITIS PATIENTS IN REAL LIFE: A 24-MONTHS PROSPECTIVE MULTICENTRIC STUDY

Increased Keratin 9 expression in Systemic sclerosis skin is driven by the lncRNA HOTAIR from fibroblast derived exosomes EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start Cardiovascular and disease related features in axial spondylitis with and without concomitant psoriasis. A multicenter study with 882 Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) patients.

Deep phenotyping of dermatomyositis based on lipid ferroptosis-related genes by Machine Learning Clinical characterization and predictive factors for progression in a cohort of ILD patients with features of autoimmunity: Are IPAF criteria sufficient?

Meteorological variables have different influence on core measures of disease activity in patients with rheumatoid arthritis SARS-CoV2 serology screening in spondyloarthritis patients in North-Eastern Italy: a pilot study Fall risk assessment in rheumatoid arthritis patients Specificity of pANCA autoantibodies in autoimmune diseases

LOW PRECONCEPTIONAL COMPLEMENT LEVEL IS RELATED WITH ADVERSE OBSTETRIC OUTCOME IN A MULTICENTRIC COHORT OF PREGNANCY IN PATIENTS WITH APS AND aPL POSITIVITY Unusually high prevalence of atrial fibrillation in patients with rheumatoid arthritis. Regulation of IFN signature by HDAC class IIa-CD52 axis in systemic sclerosis Adoption of digital manikins to self-report pain: a systematic review

Speckle tracking better detects subclinical myocardial dysfunction in patients with rheumatoid arthritis

Factors associated with use of telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak

Risk of cardiovascular disease in newly diagnosed rheumatoid arthritis: a current risk assessment

Survival analysis of time to first adverse drug reaction and drug survival in rheumatoid arthritis patients treated with methotrexate and hydroxychloroquine monotherapies or combination therapy

National Burden of Rheumatoid Arthritis in Canada 1990-2017: Findings from the Global Burden of Disease Study 2017

How does multimorbidity impact on the direct and indirect costs in patients with rheumatoid arthritis? Co-morbidities may not Change Treatment Characteristics of the Rheumatoid Arthritis Patients SAFETY AND EFFICACY OF BELIMUMAB IN OLDER ADULTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF AN INTEGRATED ANALYSIS

ULTRASOUND-DETECTED TENOSYNOVITIS IN ANKLES WITH CLINICALLY ACTIVE DISEASE OF CHILDREN WITH NEW- ONSET JUVENILE IDIOPATHIC ARTHRITIS DOES NOT AFFECT THE CHANCE TO ACHIEVE DISEASE REMISSION Short-term risk of osteoporosis in adults treated with corticosteroids: an observational study Sexual Function Is Impaired in Women with Systemic Sclerosis Compared to Healthy Controls

Assessment of microvascular involvement in lupus nephritis patients by retinal OCT-angiography and kidney biopsies Comparison of baseline characteristics between patients continuing or discontinuing apremilast at twelve months in the REWARD study (The Netherlands) Factors influencing patient-reported outcomes in ANCA-associated vasculitis Predictors of 1-year treatment response among upadacitinib-treated patients with ankylosing spondylitis: A post hoc analysis of SELECT-AXIS 1 Improvements in Patient-Reported Outcomes in Rheumatoid Arthritis Patients Treated With Golimumab: Sub-Analysis of Asian Patients Enrolled in Phase-3 Clinical Trials Association between immune-serological profile and pulmonary manifestations in Colombian patients with systemic lupus erythematosus (LES) SUBSPECIALTY LUPUS CLINIC CARE IS ASSOCIATED WITH HIGHER QUALITY FOR PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS Filgotinib Demonstrates Clinical Efficacy in Rheumatoid Arthritis Independent of Smoking Status: A Post-Hoc Subgroup Analysis of Three Phase 3 Clinical Trials Real-World Economic Implications of Achieving Low Disease Activity in Lupus Nephritis Comorbidity and long-term outcome in patients with congenital heart block: preliminary data of the Italian Registry on the Immune- Mediated Congenital Heart Block.

Extrapolation of long-term outcomes in systemic lupus erythematosus: replicating a Hopkins Lupus Cohort analysis with the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort Spondyloarthritis and sleep disorders Consistent Efficacy With Apremilast in Men and Women to Treat Oral Ulcers Associated With Behçet’s Syndrome: Phase 3 Relief Study Results 40 (IL-40) is up-regulated in rheumatoid arthritis (RA) and associated with disease activity, levels of autoantibodies and chemokines Socio-economic impact of Sjögren's syndrome in Western Switzerland: a cross-sectional study The dynamics of inflammatory markers in COVID-19 patients treated with levilimab

PATIENT PREFERENCES, TRADE-OFFS AND ACCEPTABLE RISKS IN THE TREATMENT OF SYSTEMIC SCLEROSIS- ASSOCIATED INTERSTITIAL LUNG DISEASE: A STEP TOWARDS SHARED DECISION-MAKING

Easy-BILAG: a new tool for faster and more accurate recording of BILAG-2004 disease activity in SLE

Sexual Function Is Impaired in Women with Idiopathic Inflammatory Myopathies Compared to Healthy Controls

Short-term effect of anti-IL-6 therapy on adiponectin serum levels in patients with rheumatoid arthritis IMPACT OF AND ANAKINRA ON PATIENT-REPORTED OUTCOMES IN ADULT-ONSET STILL’S DISEASE PATIENTS EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start Evolution of anti-modified protein antibody responses can be driven by consecutive exposure to different post-translational Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) modifications

Prevalence of COVID-19 among patients with rheumatic diseases: an observational survey during the two waves in Italy

Therapeutic management of rheumatologists versus otorhinolaryngologists of cervicogenic dizziness Findings consistent with subclinical vasculitis in patients with new onset polymyalgia: a systematic literature review and a meta-analysis of cohort data

Rheumatoid arthritis and interstitial lung disease: prevalence and drug prescriptions in German claims data

Factors Associated with Baseline Hypertension in Early Rheumatoid Arthritis : Data from a Real-World Large Incident Cohort

Unsupervised Clustering Identifies Unique Subsets of Patients in a Racially and Ethnically Diverse Rheumatoid Arthritis Cohort. Impact of rheumatoid arthritis on stress: a systematic scoping review Risk Factors for Hospitalization in Patients with Systemic Lupus Erythematosus: a Latin Cohort

Ixekizumab shows a distinct pattern of pain improvement beyond inflammation in radiographic axial spondyloarthritis

ANALYSIS OF BIOLOGIC THERAPY RETENTION RATE IN PSORIATIC ARTHRITIS PATIENTS WITH AND WITHOUTV AXIAL INVOLVEMENT. DATA FROM CLINICAL PRACTICE

Presence of four serum autoantibodies associates with the ACPA status in early rheumatoid arthritis Diagnosis of osteoporosis using Radiofrequency Echographic Multi Spectrometry (REMS) at the lumbar spine in patients with different Body Mass Index

MiRNAs correlate with improvement in disease activity in patients with rheumatoid arthritis on tumour necrosis factor inhibitors Pregnancy in SLE patients treated with belimumab: experience from 3 Italian Centers

Hypoglycaemia following JAK inhibitor treatment in diabetes mellitus patients with rheumatoid arthritis Patient perspectives of biologic treatments for axial spondyloarthritis: satisfaction, wear-off between doses, and use of supplemental medications Guselkumab Provides Sustained Improvements in Work Productivity and Non-work Activity in Patients With Psoriatic Arthritis: Results Through 1 Year of a Phase 3 Trial Identification of autophagy-related phenotypes in primary Sjogren's syndrome Gene expression microarray in lupus nephritis by bioinformatic analysis

Impact of COVID-19 pandemic on adherence behavior of Latin-American patients with rheumatic diseases Disease control in psoriatic arthritis patients with or without axial manifestations in real clinical practice in Spain: Results from the midas study Hydroxychloroquine Induced Retinal Toxicity In Patients with Rheumatic Diseases Targeting JAK-STAT signalling alters the phenotypic characteristics of PsA synovial fibroblasts in response to the JAK/STAT activator oncostatin M The development of a novel ePRO delivery system to measure patient quality of life in routine clinical care: An analysis of 5 years of experience The Collaboration of Rheumatology-Dermatology in the Evaluation of Rheumatic Diseases Patients: Experience in a University Hospital

EPIDEMIOLOGY OF LATENT TUBERCULOSIS INFECTION IN PATIENTS WITH RHEUMATIC IMMUNE-MEDIATED DISEASES. SINGLE UNIVERSITY STUDY OF 1117 PATIENTS Safety and efficacy of Anakinra in severe SARS-CoV2 infection (COVID19) at a tertiary hospital Evaluation of the intima-media thickness index by carotid Doppler in patients with Rheumatoid Arthritis at Hospital Docente Padre Billini, Dominican Republic

SAFETY OF BELIMUMAB IN ADULT PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A LARGE INTEGRATED SAFETY ANALYSIS OF CONTROLLED CLINICAL TRIAL DATA

Non-Radiographic Axial Spondyloarthritis In The Afro-Caribbean Population, Clinical Aspects And Particularities Prevalence and correlates of underweight, overweight and obesity among patients with juvenile idiopathic arthritis (JIA): Evidence from the National paediatric rheumatologic database (NPRD)

DISCORDANCE BETWEEN PATIENT’S AND PHYSICIAN’S DISEASE ACTIVITY ASSESSMENT IN RHEUMATOID ARTHRITIS: WHICH DOMAINS CAN INFLUENCE THIS DISCREPANCY WHEN REMISSION IS ACHIEVED? Clinical manifestations of SARS-CoV2 infections in children and adolescents with rheumatic and musculuskeletal diseases – survey data from Germany The influence of escalated PGA score on disease activity, daily activity, and quality of life, and solution for optimal PGA level that deserves clinical remission in patient with rheumatoid arthritis

Interstitial lung involvement in Systemic Lupus Erythematosus: Relevant clinical characteristics. Our experience in a third level hospital.

PREGNANT AND POSTPARTUM WOMEN WITH AUTOIMMUNE RHEUMATIC DISEASES AND COVID-19: A CASE SERIES

Effect of Biologic DMARDs Treatment on Gene Expression and Activity of Natural Killer Cells in Rheumatoid Arthritis

Effects of serial locally applied water-filtered infrared A radiation in patients with systemic sclerosis with severe raynaud's syndrome receiving prostaglandine treatment – a randomized controlled trial EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start

Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) Anti-acetylated protein antibodies in rheumatoid arthritis (RA): clues for the starting point of autoantibody responses in RA

Treatment pathways of rheumatoid arthritis patients leading to biologic therapy visualized in a Sankey diagram ANTI INFLIXIMAB ANTIBODIES DETECTED BY A DRUG TOLERANT ASSAY ARE FREQUENT BUT, IN MANY CASES, WITHOUT RELEVANT CLINICAL SIGNIFICANCE The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profile

The subgroup of ACPA-negative rheumatoid arthritis patients achieving sustained DMARD-free remission is characterized by a different response in serological markers within the first year of DMARD-initiation Tofacitinib treatment in patients with psoriatic arthritis and probable depression and/or anxiety: a post hoc analysis of two Phase 3 clinical trials A change in a rehabilitation model increases work capacity at 36 months in low back pain MAPPING THE NATIONWIDE CLINICAL PROFILE AND PATTERNS OF CARE OF SLE IN BRAZIL – FINDINGS FROM THE MACUNAÍMA STUDY ANTIINFLAMMATORY, ANTIOXIDANT AND ANTI-ATHEROSCLEROTIC EFFECTS OF A COMBINATION OF NATURAL SUPPLEMENTS ON PATIENTS WITH FMF RELATED AA AMYLOIDOSIS: A NON-RANDOMIZED 24 WEEKS OPEN LABEL INTERVENTIONAL STUDY

STATE OF ADIPOCYTOKINES IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH SUBCLINICAL ATHEROSCLEROSIS Drug Survival for IL-6 Inhibitor Tocilizumab: data from a single-center observation

The Prevalence of Hypertension and Its Potential Associated Factors in Chinese Patients with Rheumatoid Arthritis Is imaging detected joint inflammation helpful in explaining fatigue in rheumatoid arthritis at diagnosis and during the disease course? – a large MRI study Cardiovascular disease risk in inflammatory arthritis patients still substantially elevated in 2020

High dose intravenous pulse Methotrexate in refractory Eosinophilic Fasciitis: What are the Adverse Events? Effect of carotid ultrasound on the achievement of LDL-cholesterol targets in the routine clinical care of patients with Rheumatoid Arthritis

CAN LOW-DOSE ASPIRIN DURING PREGNANCY PREVENT THE DEVELOPMENT OF ADVERSE PREGNANCY OUTCOMES IN WOMEN WITH ARTHRITIS? DATA FROM THE P-RHEUM.it STUDY

Study of methotrexate metabolites concentrations in red blood cells and mononuclear cells in rheumatoid arthritis

How has our management of SLE changed over the last three decades? Real life data from a monocentric cohort Efficacy and Safety of Belimumab in patients with Lupus Nephritis in Real-Life setting: results from a large, nationwide, multicentric, prospective cohort Functional impact of forefoot involvement in rheumatoid arthritis Accuracy and performance of a handheld ultrasound device to assess articular and periarticular pathologies in patients with inflammatory arthritis Psychiatric disorders in juvenile idiopathic arthritis - a population-based cohort study

Pain Is an Independent Associated Factor on Functional Limitation in Chinese Patients with Early Rheumatoid Arthritis Glucocorticoid discontinuation in early rheumatoid and undifferentiated arthritis patients. A sub-analysis of the BeSt and IMPROVED studies.

Reduced Bone Mineral Density in Patients with Idiopathic Inflammatory Myopathies: A Case control Study THE REMITTING SERONEGATIVE SYMMETRICAL SYNOVITIS WITH PITTING EDEMA SYNDROME (RS3PE): REVIEW OF TEN YEARS AT A REFERENCE HOSPITAL

Blunted cerebral oxygenation during exercise in non-neuropsychiatric systemic lupus erythematosus

CHARACTERISTICS OF GIANT CELL ARTERITIS FLARES AFTER SUCCESSFUL TREATMENT WITH TOCILIZUMAB: RESULTS FROM THE LONG-TERM EXTENSION OF A RANDOMIZED CONTROLLED PHASE 3 TRIAL Usefulness of FDG-PET/CT for predicting spontaneous regression in MTX associated lymphoproliferative disorder with rheumatoid arthritis. A novel Grey Scale and Power Doppler ultrasonographic score for idiopathic inflammatory myopathies: Siena Myositis Ultrasound Grading Scale. Associations between HLA-DRB1 shared epitopes alleles and anti-RA33 antibodies in different subsets of rheumatoid arthritis in Malaysian population SARS-COV-2 VACCINE HESITANCY AMONG PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES: A MESSAGE FOR RHEUMATOLOGISTS. Identifying adult hypophosphatasia in the rheumatology unit A Biomarker Profile Aiding An Early Diagnosis of Giant Cell Arteritis Influence of Colchicine prescription in COVID19-related hospital admissions: A survival analysis Quantitative autofluorescence findings in patients undergoing hydroxychloroquine treatment Temporal trends and factors associated with vitamin D prescription and intake

Detection of ABCG2 variants in encoding of urate transporters associated with the hyperuricemia in haemodialysis patients

In depth identification of risk factors for severe COVID-19, requiring hospitalization, in patients with inflammatory rheumatic diseases: results of a Dutch nested case control study (preliminary results)

Association between body shapes and body shape trajectories, and the risk of Rheumatoid Arthritis in the French E3N cohort. EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) ACPA status correlates with differential immune profile of Rheumatoid Arthritis Patients

Non-steroidal anti-inflammatory drug use is associated with disease activity and reduced significantly in patients with axial spondyloarthritis treated with tumor necrosis factor inhibitors; data from a real life experience Efficacy and safety of two courses of Rituximab Biosimilar Acellbia in patients with interstitial lung disease associated with systemic sclerosis: a prospective observational study Optimal assessment of the rheumatoid arthritis ankle and hindfoot: A comparative study between clinical examination and ultrasonography

Histopathologic patterns of lupus nephritis predict the risks of mortality- a single-center retrospective study

Patient Characteristics and Outcomes in Patients with Rheumatoid Arthritis Treated with Upadacitinib: The OM1 RA Registry During development of rheumatoid arthritis, intermetatarsal bursitis may occur before clinical joint swelling: a large MRI study in patients with clinically suspect arthralgia

Low prevalence of SSA (anti-Ro) and SSB (anti-La) autoantibodies in female rheumatoid arthritis patients with a wish to conceive

High Correlations Between Question 1 & 2 of the BASFI: an Opportunity to Streamline the BASFI The effects and safety of apremilast and cytokine expression in Behcet's disease patients Experience with COVID-19 in German paediatric rheumatology centres

Normalization of high sensitivity CRP versus clinical response to ixekizumab at week 16 in patients with radiographic & non- radiographic axial spondyloarthritis: Results from the COAST studies

Comparison of two approaches in fractures risk assessment in women with rheumatoid arthritis and glucocorticoid use

Scores of cardiovascular risk calculators as predictors of early atherosclerosis in patients with rheumatoid arthritis

Rheumatoid arthritis per se is not risk factor for clinical fractures: Nine-year findings of the TOMORROW study Baricitinib Provides Greater Improvements in Patient-Reported Outcomes Across All Disease Activity Levels Compared to Placebo and Adalimumab in Rheumatoid Arthritis

Prevalence and Associated Factors of Sleep Disorders in Patients with Axial Spondyloarthritis. Results from the Spanish Atlas

Factors Associated with Pain Intensity in Axial Spondyloarthritis. Results from the European Map of Axial Spondyloarthritis (EMAS) CLINICAL ASSOCIATIONS OF ANTI-RO52 ANTIBODIES IN PATIENTS WITH SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES Comparative efficacy of TNF inhibitors versus other cytokine inhibitor bDMARDs on psoriatic arthritis impact of disease (PsAID) score and domains.

Decrease in anti-topoisomerase-1 antibody titer in patients with systemic sclerosis during long-term rituximab therapy

Tenosynovitis has a high sensitivity for early ACPA-positive and ACPA-negative RA: a large cross-sectional MRI study

Best cardiovascular risk calculator to predict abnormalities in left ventricular geometry in Rheumatoid Arthritis

Anifrolumab, an Anti-Interferon-α Receptor in Systemic Lupus Erythematosus- A Meta Analysis Prevalence of axial spondyloarthritis among young people consulting because of chronic low back pain in a University Hospital in Argentina. Identification of molecular phenotypes in systemic sclerosis by integrative systems analysis

Serum proteomics reveals insulin-like growth factor binding proteins-1 as biomarkers for idiopathic multicentric Castleman's disease Allelic variants in the ABCG2 gene can lead to hyperuricemia and gout EPIDEMIOLOGY OF LUPUS NEPHRITIS IN BRAZIL: FINDINGS FROM THE MACUNAÍMA STUDY - A NATIONWIDE MULTICENTRIC STUDY Pharmacokinetics of Pegloticase and Methotrexate Polyglutamate(s) in Patients with Uncontrolled Gout Receiving Pegloticase and Co- treatment of Methotrexate Average prednisolone dose of only 1 mg per day was risk factor for clinical fractures in patients with rheumatoid arthritis - Nine-year findings of the TOMORROW study- Autoimmunity Against Collagen in Rheumatoid Arthritis (RA): Serum Levels of IgG Against Denatured Type II Collagen Significantly Elevated in RA

The relationship of genetics and clinically suspect arthralgia in RA development assessed using HC, CSA and RA patients

Association between higher intake of carbohydrates and free sugar with higher disease activity in patients with axial spondyloarthritis Acute Kidney Injury (AKI) in patients with rheumatoid arthritis (RA)

Biological reproducibility of targeted lipidome analyses in plasma and erythrocytes over a 6-week period

Investigating the anti-inflammatory potential of a novel MK2 inhibitor in a vitro model of enthesitis

Comparative metabolomic analysis of serum samples from patients with coincidental rheumatological and malignant diseases

Clinicians' perspectives on psychological distress and meeting patients' support needs in rheumatology care settings

INFLUENCE OF CONFINEMENT CARRIED OUT BY PATIENTS WITH AUTOIMMUNE AND IMMUNE- MEDIATED INFLAMMATORY DISEASE WITH BIOLOGICAL TREATMENT ON COVID-19 INFECTION EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start

Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) Two-dimensional HRCT-based radiomic features in SSc-ILD distinguish drug responders from non-responders Factors associated with the development of anti-drug antibodies to tumour necrosis factor inhibitors in patients with axial spondyloarthritis; a two year follow-up study Factors Associated with Inability to Work and Disability in Patients with Axial Spondyloarthritis. Results from the European Map of Axial Spondyloarthritis (EMAS) Fibrin Deposition is an Active Trigger of Cartilage Degeneration in Rheumatoid Arthritis Tocilizumab is safe and effective in elderly patients with rheumatoid arthritis Pain catastrophizing is associated with residual pain after reaching improved conditions of swollen/tender joints and serum C-reactive protein level OCULAR SCLERAL PATHOLOGY. UNDERLYING DISEASES AND SYSTEMIC TREATMENT. STUDY OF 175 PATIENTS FROM A SINGLE UNIVERSITY CENTER. Disease control perception by physicians and patients with ankylosing spondylitis and psoriatic arthritis in real clinical practice in Spain: MIDAS study results

Arthritic pain as a surrogate marker for asymptomatic cardiovascular risk factors: offering practitioners a ‘teachable moment’

Association of anti-citrullinated protein antibodies of IgA subclasses with sustained remission and flare in rheumatoid arthritis.

Prevalence and relevance of antibodies against citrullinated alpha enolase (anti-CEP1) in connective tissue diseases

NAILFOLD CAPILLAROSCOPY IN UNDIFFERENTIATED AND MIXED CONNECTIVE TISSUE DISEASES Effect of Filgotinib on PASDAS: Drivers of Low and Very Low Activity up to Week 100 Identification of molecular phenotypes and immune cell infiltration in systemic lupus erythematosus patients according to longitudinal gene expression

Screening and Bioinformatics Analysis of hub genes and pathways for primary Sjögren's Syndrome Based on GEO database Associations of remission and persistence of biologics at 1 and 12 years

Clinical characteristics of patients with systemic sclerosis and gastric antral vascular ectasia (GAVE) NEUTROPHIL AND MONOCYTE EXTRACELLULAR TRAPS IN RHEUMATOID ARTHRITIS: POTENTIAL SOURCE OF DIAGNOSTIC BIOMARKERS

TOLEROGENIC DENDRITIC CELLS IN RHEUMATOID ARTHRITIS PATIENTS: NEWS AND PROMISES

Wood smoke exposure is associated with higher Anti-CCP antibody titers in Hispanic Patients with Rheumatoid Arthritis.

Money matters: Assessing the value of the adalimumab biosimilar switch for Rheumatology patients Disease Activity in Pregnant Women with Rheumatoid Arthritis: Impact on the Soluble Fms-Like Tyrosine Kinase-1 to Placental Growth Factor Ratio Secukinumab in patients with psoriatic arthritis and axial manifestations: Predictors of response from the double-blind, randomised, phase 3b MAXIMISE trial

Rheumatic manifestations in COVID-19 patients - single-center experience amidst the pandemic

Integrative clinical, molecular and computational analyses allow the identification of distinctive phenotypes of Rheumatoid Arthritis patients related to the clinical involvement and the response to TNF inhibitors. Oral dysbiosis reflects the immunological alteration of RA regarding to HLA DRB1*SE, ACPA and cigarette smoking : Nagasaki Island Study

Association of neutrophil lymphocyte and platelet lymphocyte ratios with joint inflammation in rheumatoid arthritis

Determining Circulating Endothelial Cells using CellSearch System in Systemic Sclerosis patients Reliability of vertebral fracture assessment on dual-energy X-ray absorptiometry THE BLOOD T-CELL SUBSETS IN RHEUMATOID ARTHRITIS PATIENTS ON LONG-TERM IL-6 RECEPTOR BLOCKER THERAPY

Clinicogenetic study of five novel susceptibility loci for Takayasu arteritis: susceptibility loci in the IL12B and PTK2B region, but not the LILRA3, DUSP22, KLHL33 regions, are associated with vascular damage in Takayasu Arteritis Multivariate Analysis of Risk Factors for Reduced Bone Mineral Density assessed with Radiofrequency Echographic Multi Spectrometry (REMS)

Using lipidomics to predict prednisolone treatment response in patients with inflammatory hand osteoarthritis: The HOPE study The association of stigma with disease variables in patients with fibromyalgia (FM) Impact of Rheumatoid Arthritis on Left Ventricular Remodeling EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start Cytokine production by blood lymphocytes defines a profile associated with non-remission in patients with rheumatoid arthritis treated Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) with TNF inhibitors EPIDEMIOLOGY AND CLINICAL FEATURES OF OCULAR SARCOIDOSIS. STUDY OF 65 PATIENTS OF A SERIES OF 384 PATIENTS FROM A SINGLE UNIVERSITY HOSPITAL. Successful treatment of severe COVID-19 pneumonia and cytokine release with simultaneous tocilizumab and anakinra with one- month follow-up

First-in-Human Study of GS-5718, an Oral IRAK-4 Inhibitor, in Healthy Subjects: Pharmacokinetics, Safety, Tolerability, and Assessment of Effect of Food and Acid Reducing Agents on Exposure

The characteristics of systemic lupus erythematosus who have constitutional symptoms and lymphadenopathy

Retinal vessel calibers as a non-invasive biomarker of inflammatory burden in Primary Systemic Vasculitis The arthritis component of the SLEDAI should only be scored if there is joint swelling

Identification of hub genes and molecular pathways in patients with rheumatoid arthritis by bioinformatics analysis. Serum uric acid-to-creatinine ratio: a potential marker for gout Diastolic dysfunction associated with increased activity in Rheumatoid Arthritis. Which Prognostic Factors might predict the need for treatment adaptation in early Rheumatoid Arthritis? A comparison of machine learning, survival analysis and regression methods.

Validation of ANCA-Associated Vasculitis as the Cause of End-Stage Renal Disease in the United States Renal Data System Real World Population-based Assessment of COVID-19 Outcomes Among Rheumatoid Arthritis Patients Using Biologic or Synthetic DMARDs Trends and predictors of inpatient mortality in patients with Clostridiodes difficile infection among those with and without rheumatoid arthritis: A Nationwide analysis Cluster analysis of ankylosing spondylitis patients reveals differential drug survival of anti-TNF agents according to distinct clinical phenotype Systemic Lupus Erythematosus (SLE) Diagnosed During Hospitalization: Clinical Phenotype and Performance of the SLE Risk Probability Index (SLERPI) Effectiveness and Safety of Tocilizumab in patients with systemic sclerosis: a propensity score control matched observational study of the EUSTAR cohort

Influence of Eating Habits on Frailty among Patients with Rheumatoid Arthritis: KURAMA Cohort Relationship between hindfoot deformities and ultrasound tenosynovitis in rheumatoid arthritis Performance of ASDAS versus BASDAI during pregnancy Familial Mediterranean Fever During Pregnancy: A 26 Case Series With 38 Pregnancies The natural course of rheumatoid arthritis-associated interstitial lung disease focusing on lung physiology: a prospective observational cohort study (Part 1) High disease activity at baseline and seropositivity are associated with treatment response at one year post synovial biopsy in rheumatoid arthritis patients

Geographic Variation of Ankylosing Spondylitis (AS) Diagnosis and Treatment in the United States: A Real-World Evidence Study

LOW POSITIVITY RATE IN ANTIBODY SARS-COV2 TESTS IN PATIENTS WITH RHEUMATIC DISEASES TREATED WITH RITUXIMAB. A CASE CONTROL STUDY OF A HIGH IMPACT SARS-COV2 INFECTION AREA. IL-6 higher level after Tocilizumab treatment as a predictor of not-survival in COVID19 severe pneumonia: the experience of the COVIBAS-study

“Where does it hurt?”: Identifying pain content and its context within paediatric and adolescent rheumatology training NAD+ Boosters reestablish the altered NAD+ metabolism of Leukocytes from Rheumatoid Arthritis patients improving their Oxidative, Apoptotic and Inflammatory Status

The Importance of Physical Activity in relation to being Overweight/Obese with Axial Spondyloarthritis. Results from the Spanish Atlas The Impact of Axial Spondyloarthritis on Patients’ Sexual Life: Results from the Spanish Atlas Incidence and outcome of COVID-19 in ANCA-associated vasculitis: impact of COVID-19 in patients undergoing rituximab for maintenance Causes of Hospitalization in Behçet Syndrome

Patients’ perspective on continuation versus temporary interruption of immunomodulatory agents during infections in patients with immune-mediated inflammatory diseases: An interview study Does older really mean wiser?

A novel mechanism linking mucosal bacteria with autoantibody responses in RA: acetylated bacterial lysate as a model antigen EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start

Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) Age at onset in axial spondyloarthritis around the world: data from the international ASAS-perSpA study Diagnostic value of SPECT/CT in axial spondyloarthritis and other low back pain. Efficacy of Secukinumab in TNFi-naïve Patients across the axial Spondyloarthritis Spectrum over 52 weeks: A Post hoc Analysis of the MEASURE and PREVENT Clinical Trials The impact of COVID-19 on patient management and prescribing strategy across the EU and US: A real-world survey of rheumatologists, dermatologists, and gastroenterologists

Clinical responses to upadacitinib or abatacept in patients with rheumatoid arthritis by type of prior biologic disease-modifying antirheumatic drug: Data from the phase 3 SELECT-CHOICE study

Impact of the EULAR HCP core competencies on Rheumatology Physiotherapists in the UK: survey results.

Changes of RF isotype profile in patients with rheumatoid arthritis: data from 10 years follow-up study

Query algorithms and machine learning methods as tools to identify comorbidities in large-scale free-text based fields: a case-report.

The pattern of COVID 19 pandemic among patients with autoimmune inflammatory rheumatic diseases (AIIRD)

Routine Assessment of Patient Index Data 3 (RAPID3) in patients with rheumatoid arthritis treated with long-term upadacitinib therapy

Circulating microRNA profiling in patients with Anti-synthetase syndrome and interstitial lung disease The impact of flares on patient reported outcomes in rheumatoid and undifferentiated arthritis patients – a sub-analysis of the IMPROVED study Computed tomography-based assessment of radiographic progression in spine and sacroiliac joints after pregnancy in women with ankylosing spondylitis

Treatment response to tumor necrosis factor inhibitors in adults with juvenile idiopathic arthritis: Data from the NOR-DMARD study Substantial impact of autoantibody enrichment on outcomes in early rheumatoid arthritis treated with abatacept: data from a large pooled analysis of 4 RCTs Persistence of Tfh cells after rituximab is associated with IgG4-related disease relapse Symptom rates, attitudes and medication adherence of rheumatic and musculoskeletal disease patients during the SARS-CoV2 pandemic Identification of Potential Crucial Genes and Key Pathways in pulmonary arterial hypertension with systemic sclerosis by Bioinformatic Analysis

Deep phenotyping of Psoriasis based on lipid metabolism related genes by integrative systems analysis

Analysis of primary care consultation patterns to aid diagnosis of Axial Spondyloarthritis – an exploratory case series Is it possible to identify individuals at imminent-risk of sub-clinical joint involvement?

Effect of sex in co-existent fibromyalgia and enthesitis in spondyloarthritis: ancillary analysis of the ASAS-PerSpA study MyRA Touch For Disease Activity Evaluation In Rheumatoid Arthritis: A Comparison Of Patient-Reported Outcomes With Physician’s Assessment Response to Biologic Therapy in Rheumatoid Arthritis: Rethinking Our Classification Failure to sustain treatment target after tapering tocilizumab in patients with rheumatoid arthritis: 4-year longitudinal data from a nationwide cohort Juvenile idiopathic arthritis in the context of the coronavirus disease 19 pandemic: impact on the decrease in treatment and the return to school

The accuracy of osteoporotic fracture risk prediction in patients with rheumatoid arthritis using the predictive model developed at V.A. Nasonova Reasearch Institute of Rheumatology (Russia) and Fracture Risk Assessment Tool (FRAX)

Medical cost and resource use in patients starting treatment for rheumatoid arthritis treated with and without corticosteroids in Japan

The Relation between Involvement of Individual Joints of the Upper Extremity and Grip Force in Early Rheumatoid Arthritis Canakinumab is a rescue treatment for macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis: single center experience.

NETAKIMAB EFFICACY IN ANTI-TNF-NAIVE AND ANTI-TNF-EXPERIENCED PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS OF SUBANALYSIS OF PHASE 3 ASTERA TRIAL

SECUKINUMAB LEADS TO IMPROVEMENT ACROSS PSORIATIC ARTHRITIS MANIFESTATIONS OVER 2 YEARS REGARDLESS OF PREVIOUS EXPOSURE TO A TNF INHIBITOR: A POST HOC ANALYSIS OF FUTURE 5 Peritenon thickening is associated with the intensity of manual sports activity. Pulmonary findings on high-resolution computed tomography in Takayasu arteritis

Interval between symptom onset and diagnosis among patients with autoimmune rheumatic diseases in a multi-ethnic Asian population Different clinical relevance of anti-citrullinated proteins antibodies in RA patients EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) Identification of hub genes and pathways in dermatomyositis by bioinformatics analysis Efficacy and Safety of Intravenous Golimumab in Ankylosing Spondylitis Patients With Early vs Late Disease Through Week 52 of GO- ALIVE Study

Efficacy and safety of Acemetacin in the treatment of 1215 active ankylosing spondylitis patients: Data from a prospective cohort managed by Smart-phone SpondyloArthritis Management System

Inflammation of the hip joints in early axial spondyloatritis: data analysis of visualization methods.

Contextual factors should complete the assessment of functioning in patients with axial Spondyloarthritis (axSpA)

Differentiating the dominance of pulmonary vascular disease or interstitial lung disease on hemodynamic abnormalities in systemic sclerosis and clarifying each characteristic by using quantitative evaluation of chest CT

Non-Rheumatologists find it difficult to Identify Axial Spondyloarthritis in Women and Young people. Results from the Spanish Atlas

Greater Reduction in CLASI-A Scores Achieved With BIIB059 Versus Placebo Independently of Disease Severity at Baseline Retention Rate and Treatment Response of Biological Agents in Advanced Spinal Ankylosis and Bamboo Spine: The Real Life Data from the HUR-BIO Registry

Exogenous CXCL5 restores endogenous blood-tissue chemokine gradient to improve survival in murine lupus SCLERODERMIC HAND SENSOR: SMART TECHNOLOGY APPLIED TO RHEUMATOLOGY

Influence of baseline demographics on improvements in disease activity measures in patients with ankylosing spondylitis receiving upadacitinib: A post hoc subgroup analysis of SELECT-AXIS 1 Modelling of disease activity in patients with inflammatory arthropathies treated with etanercept originator or biosimilar as first-line biologic in an Australian real-world dataset. Assessing antibody status for SARS-CoV-2 in people with coronavirus infection: a time course study in people with autoimmune conditions

DEVELOPMENT OF A CONCEPTUAL MODEL TO UNDERSTAND DISEASE BURDEN IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND LONG-TERM ORGAN DAMAGE

Sexual function in male and female patients with rheumatoid arthritis: a post-hoc analysis of the FINCH studies

Morning stiffness in clinically suspect arthralgia is explained by local subclinical synovitis and systemic inflammation. Efficacy and safety of levilimab in combination with methotrexate in subjects with active rheumatoid arthritis: phase III, double-blind, placebo-controlled, randomized trial Secukinumab Improves Physical Function and Inhibits Structural Damage in PsA Patients with Sustained Remission or Low Disease Activity: Results from a Phase 3 Study

High satisfaction with ustekinumab treatment in patients with active psoriatic arthritis – Final results of the non-interventional study SUSTAIN demonstrate early and long-term treatment response and high tolerability Upadacitinib Pharmacokinetics and Exposure-Response Relationships for Efficacy and Safety in Psoriatic Arthritis – Analyses of the Phase 3 SELECT-PsA Studies Long-term effectiveness after multiple cycles with rituximab following an on-flare retreatment strategy in patients with Rheumatoid Arthritis attenuates disease activity in seronegative RA patients – preliminary data from a non-interventional study in regular care in Germany Immunosuppressants (Cyclophosphamide and Mycophenolate Mofetil) versus Rituximab a single-agent therapy in Scleroderma- related Interstitial Lung Disease: real clinical practice. Evaluation of the Effectiveness of Mobile App-based Exercises Programme in Patients with Neck Pain: The Randomized Controlled Trial NAILFOLD CAPILLARY DILATIONS IN RAYNAUD’S PHENOMENON: QUANTIFYING A PREDICTIVE THRESHOLD FOR THE ‘SCLERODERMA PATTERN’

Realizing early recognition of arthritis in times of increased telemedicine: The value of patient-reported swollen joints Impact of the COVID-19 Pandemic and Lockdown on Wellbeing on Patients with Rheumatic Diseases. Results from the REUMAVID Study (Phase 1) Simultaneous assessment of joint and vascular inflammation by PET-CT in tofacitinib-treated patients with rheumatoid arthritis: a prospective study PREDICTIVE FACTORS ASSOCIATED WITH DEVELOPMENT OF PSORIATIC ARTHRITIS IN PATIENTS WITH UNDERLYING PSORIASIS Improvement in the diagnostic delay of axial spondyloarthritis, results from real world data Sexual dysfunction in male patients with rheumatic diseases

Psoriatic arthritis and obesity impact drug persistence in ustekinumab-treated patients with psoriasis in the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR): A 10-year follow-up study EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start PREDICTORS OF DISEASE PROGRESSION IN A MONOCENTRIC COHORT OF 100 PATIENTS WITH CHILDHOOD-ONSET Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) SYSTEMIC LUPUS ERYTHEMATOSUS

Axial psoriatic arthritis and ankylosing spondylitis. Same or different? A real-world study with emphasis on comorbidities RAS Guanyl Releasing Protein 1 (RASGRP1) in peripheral B Cells links RA to COVID-19 Prediction of Rheumatoid Arthritis Disease Activity by an Adaptive Deep Neural Network: Better Results in Seropositive Patients with Longer Disease Duration Post-trial survey of participants of a Phase 3 clinical trial in SSc-ILD RENAL DYSFUNCTION AND METABOLIC CHANGES IN PATIENTS WITH RHEUMATOID ARTHRITIS ARE ASSOCIATED WITH ANGIOPOIETIN-LIKE PROTEIN TYPE 4 A quantitative assessment of the likelihood that patients with rheumatoid arthritis will communicate information about rheumatoid arthritis risk to relatives.

Potential Efficacy Predictors Of Anti-B-Cell Therapy In the Patients with Systemic Sclerosis Associated With Interstitial Lung Disease

Ultrasound-guided Core Needle Biopsy for salivary gland enlargement in Sjögren’s syndrome: procedure safety and patient tolerance Low-intensity pulsed electromagnetic fields improve physical performance in a dose-dependent manner: an observational study in older adults with rheumatic diseases. Factors Associated with Engaging in Physical Activity in Axial Spondyloarthritis. Results from the European Map of Axial Spondyloarthritis (EMAS)

Apical fibrosis and interstitial lung disease in patients with psoriatic arthritis: Do we underestimate? Characteristics of surgically treated tuberculous and brucellar spondylodiscitis Clinical characteristics of nonradiographic axial spondyloarthritis in Asian countries compared to other regions: results of the international cross-sectional ASAS-COMOSPA study Subclinical atherosclerosis in the first five years of Rheumatoid Arthritis diagnosis

The level of peripheral regulatory T cells is associated with the changes of intestinal microbiota in patients with rheumatoid arthritis Disease-specific adverse drug reaction profiles of adalimumab and etanercept as reported by immune-mediated inflammatory disease patients Real-life physical activity in SLE patients: associations with fatigue and quality of sleep Angiographic characteristics of vasculopathy in patients with connective tissue diseases.

Gender Differences in Clinical Features and Burden in Patients with Familial Mediterranean Fever : Preliminary Report

Scleroderma pattern in nailfold capillaries of (childhood-onset) systemic lupus erythematosus: lessons from longitudinal follow-up

Seroprevalence of SARS-CoV-2 Antibodies in Autoimmune Inflammatory Rheumatologic Patients Epidemiology and Outcomes of Patients with Rheumatic Diseases and SARS-CoV-2 Infection: Data from the Argentinean SAR- COVID Registry The role of SOCS3 in colchicine anti-inflammatory effect on COVID-19 infection Persistence of remission after tapering of Golimumab in inflammatory joint disease (IJD) Ultrasound synovitis, unlike enthesitis or clinical joint assessment, is associated with joint damage progression in patients with psoriatic arthritis

Clinical utility of breath-holding test for measuring cardiopulmonary function in patients with systemic sclerosis The Effect of One Dry Needling Session on Pain and Central Pain Processing in Patients With Knee Osteoarthritis: a Randomized Controlled Trial Monosodium urate crystals reduce Schwann cells viability

Treatment of Interstitial Lung Disease in Patients with Primary Sjogren syndrome: A Single-Center Retrospective Analysis Real-world effectiveness of etanercept and adalimumab in children and young people with juvenile idiopathic arthritis (JIA) without uveitis.

Regional Differences in Disease Characteristics of Familial Mediterranean Fever in Turkey: Preliminary Report Association of HLA-DRB1 haplotypes with cardiovascular mortality in Inflammatory Polyarthritis: Results from the Norfolk Arthritis Register Anti-TNF and methotrexate protect against Rheumatoid Arthritis atherosclerosis Gender differences in disease control and health status in patients with ankylosing spondylitis in clinical practice in Spain: Results of the MiDAS study

Targeted Serum Proteomic Analysis following Upadacitinib treatment in Ankylosing Spondylitis shows robust suppression of innate and adaptive immune pathways with tissue repair modulation

Predictive factors for pulmonary progression in patients with connective tissue disease and interstitial lung disease Cardiovascular Risk Factors in a Mexican Mestizo patients with Psoriatic Arthritis

Biomarkers reflecting disturbed gut barrier differ in patients with spondyloarthritis, Crohn’s disease and acute anterior uveitis EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start

TREATMENT STRATEGIES IN CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS (CMRO) OR CHRONIC NON- Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) BACTERIAL OSTEOMYELITIS (CNO): SYSTEMATIC REVIEW AND META-ANALYSIS Work Participation in Patients with Axial Spondyloarthritis in Germany: Results from a Multicenter, Observational Survey (ATTENTUS- axSpA)

SEX DIFFERENCES IN SYSTEMIC SCLEROSIS PATIENTS IN A SINGLE CENTER IN EASTERN EUROPE SARS-CoV-2 infection among patients with Behçet’s syndrome Comparative Analysis of the Clinical and Laboratory Properties of Gout, Osteoarthritis, and Calcium Pyrophosphate Deposition Disease COVID-19 vaccine willingness in RA? Results from the RA Louvain Brussels cohort Six-year results from the Esperanza Cohort: evaluation of clinical features, disease activity measures and treatment aspects in axial and peripheral early Spondyloarthritis. Rheumatological patients performing blood self-sampling for DMARD therapy safety: A proof of concept study comparing with venous blood samples. OSTEOPOROSIS AND INSUFFICIENCY RISK FACTORS IN PSORIATIC ARTHRITIS Ultrasound-guided core needle biopsy: an effective and safe tool to diagnose Sjögren`s syndrome and lymphoma of the major salivary glands

Verification of manifestations of sarcopenia in obese patients with three methods for body composition assessment Improvement in modified Rodnan Skin Score (mRSS) in Systemic Sclerosis patients treated with Rituximab: a systematic review and Meta-analysis of the Scientific literature Overlapping features of relapsing polychondritis and Sweet’s syndrome: could this be VEXAS (vacuoles, ubiquitin A1E mutation, X- linked, autoinflammatory, somatic) syndrome? Ultrasound assessment of dermal thickness and skin stiffness in undifferentiated connective tissue disease at risk for systemic sclerosis Exploring novel tenosynovitis and combined inflammation imaging outcomes: results from a randomised controlled trial in early rheumatoid arthritis PERIODONTAL DISEASE IN RHEUMATOID ARTHRITIS: RESULTS FROM A COHORT AT TREATMENT WITH BIOLOGICAL, CLASSICAL AND TARGETED SYNTHETIC DMARDs Factors associated with chronotropic response in people with rheumatoid arthritis.

DNA methylation signatures characterize psoriasis and psoriatic arthritis in monozygotic twins discordant for the disease

Investigating the Ankylosing Spondylitis-Associated Regulatory SNPs at the RUNX3 Locus with a Functional Genomics approach Incidence of gastro-intestinal complications in rheumatoid arthritis patients receiving biological DMARDs in observational cohort studies: a systematic literature review and meta-analysis Sarcopenia in myositis patients: a marker of muscle damage associated with handicap Do peripheral and extra musculoskeletal manifestations have an impact on biologic DMARD prescribing patterns in axial spondyloarthritis: the results of TREASURE experience

Quantitative CT indexes: Promising Tools for Objective Assessment of Pulmonary Fibrosis in Systemic Sclerosis Quantification of Bone Marrow Edema by MRI of the Sacroiliac Joints in Patients Diagnosed with Axial Spondyloarthritis: Results from the ESPeranza Cohort The spectrum of non-tuberculous osteoarticular infections in a rheumatology department during the years 2010-2020: a retrospective study of 102 consecutive cases in a single center.

UNMET TREATMENT NEEDS IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A CROSS-SECTIONAL ASSESSMENT OF DISEASE ACTIVITY IN SLE PATIENTS DURING THEIR LAST VISIT Evaluation of E148Q and concomitant AA Amyloidosis secondary to familial Mediterranean fever after adjusted clinical-demographic characteristics

Alteration of duodenal histology in systemic sclerosis patients after fecal microbiota transplantation The Impact of COVID-19 on rheumatology health care workers and their scientific output: heavy lies the crown on female rheumatologists ADULT-ONSET STILL’S DISEASE: A Single-Center Experience

Is bioelectrical phase angle associated with functional status and disease impact in patients with Rheumatoid Arthritis? The natural course of rheumatoid arthritis-associated interstitial lung disease focusing on lung physiology and disease activity: a prospective cohort study (Part 2) A new approach for ultrasound guided sacroiliac joint injections in spondyloarthritis Factors associated with mortality in patients with rheumatic diseases and COVID-19 in Mexico Positive impact of the first lockdown in patients with chronic inflammatory rheumatism Radiosynovectomy in a clinical setting: An underexploited tool at our disposal.

Do JIA patients response to re-treatment after a flare during tapering of bDMARDs? A descriptive study

Clinical and surrogate cardiovascular risk assessment and its relationship with Psoriatic Arthritis pathogenesis

Safety profile of Pfizer-BioNTech COVID-19 vaccine in patients with rheumatic diseases: preliminary assessment

UVEITIS IN 1449 PATIENTS WITH INFLAMMATORY BOWEL DISEASE. STUDY FROM A SINGLE UNIVERSITY CENTER

Hyperkyphosis in axial spondyloarthritis: factors that produce its appearance and effect on mobility and function. Emergence of De Novo Manifestations During Infliximab Treatment in Behçet Syndrome Comparison of demographic and clinical features of Familial Mediterranean Fever patients and patients with Axial Spondyloarthritis accompanying Familial Mediterranean Fever EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start

COMORBIDITY BURDEN IS HIGH IN RHEUMATOID ARTHRITIS AND SPONDYLOARTHRITIS PATIENTS STARTING Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) BIOLOGICS AND PREDICTS THE INCIDENCE OF SERIOUS ADVERSE EVENTS DURING THERAPY

Treatment of Polymyalgia rheumatica with TOCILIZUMAB: Results of an Observational Retrospective Multicenter Study

Familial Periodic Fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA)syndrome; is it a separate disease? Higher prevalence of subclinical atherosclerosis in Psoriatic Arthritis patients How important would be the impact of spondyloarthritis on military population's working life?

Anti-IL-6 Therapy Effect for Refractory Joint and Skin Involvement in Systemic Sclerosis: A Real-world, Single Center Experience. Disease activity and pain levels are not influenced by the current COVID19 pandemic in patients with rheumatic diseases in Germany – Data from the German COVID-19 patient survey

A novel model to assess disease activity in Takayasu arteritis based on 18F-FDG-PET/CT: a Chinese cohort study A Data Science Evaluation Of The Juvenile Arthritis Multidimensional Assessment Report (JAMAR) Questionnaire For Improving Management Of JIA Patients

Type I interferon pathway assays in patients with rheumatic and musculoskeletal diseases - Systematic literature review (SLR) and development of consensus terminology from a EULAR taskforce.

Clinical features and outcomes of COVID-19 in patients with IgG4-related disease. A collaborative European multi-centre study. Clinical and functional response to tofacitinib in patients with rheumatoid arthritis: probability plot analysis of results from a 48-week Phase 3b/4 methotrexate withdrawal study The impact of antinuclear antibodies induced by anti-tumour necrosis factor alpha agents on the long-term treatment outcomes in rheumatoid arthritis patients Complex landscape of BIRC5/survivin genome binding in human CD4+ T cells

BIOLOGICAL THERAPY IN UVEITIS ASOCIATED TO AXIAL SPONDYLOARTHRITIS. SINGLE CENTER UNIVERSITY STUDY Effectiveness and safety of original and biosimilar etanercept (Enbrel® vs Benepali®) in bDMARD-naïve patients in a real-world cohort of Portugal

Influenza infection as a trigger for systemic lupus erythematosus flares resulting in hospitalization Tuberculous spondylodiscitis in elderly: epidemiology, clinical, features, treatment and outcomes Multisystem Inflammatory Syndrome in Children During the COVID-19 Pandemic in Turkey: First Report from The Eastern Mediterranean

Rituximab for induction of remission in type 1 autoimmune pancreatitis: a systematic review and meta-analysis. HYDROXYCLOROQUINE-INDUCED ATRIOVENTRICULAR BLOCK IN IMMUNE-MEDIATED DISEASES. SINGLE UNIVERSITY CENTER STUDY OF 293 PATIENTS

ANTIRESORPTIVE THERAPY AFTER TERIPARATIDE DISCONTINUATION – WHEN IS THE BEST TIME TO STARTING IT?

Clinical and radiological manifestations of coxitis in patients with ankylosing spondylitis (AS) treated with TNF-alpha inhibitor golimumab: results of a 24-months observation (GO-COX study) Detection of Autoantibodies against Muscle-Specific Four-and-a-Half-LIM Domain 1 (FHL1) in Inflammatory Myopathies: Results from a Single-Center Cohort Performance of the new ACR/EULAR 2019 classification criteria for systemic lupus erythematosus (SLE) in a cohort of argentinian patients.

Audiologic Evaluation In Systemic Lupus Erythematosus Patients and Impact Of Hydroxychloroquine Therapy

HAVE THE CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS AN EXCESS OF ADIPOSITY? What is the role of vitamin D status in disease activity in rheumatoid arthritis patients treated with bDMARDs? – data from a Rheumatology Center Sex differences in the efficacy and safety of tofacitinib in rheumatoid arthritis patients: a post hoc analysis of Phase 3 and long-term extension trials Dysregulated CD38 expression on peripheral blood immune cell subsets in SLE Non-contiguous multifocal spondylodiscitis: a case series and review of literature

RETINOL BINDING PROTEIN 4 AS AN ACUTE PHASE REACTANT AND BIOMARKER IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER AND AMYLOIDOSIS COMPARED TO INFECTIONS

The role of chest CT in understanding interstitial lung disease (ILD): Systemic Sclerosis (SSc). versus COVID-19 RELATIONSHIP BETWEEN IMPAIRED MELATONIN SECRETION AND DURATION, RADIOLOGICAL STAGE AND PHYSICAL ACTIVITY OF RHEUMATOID ARTHRITIS Development of rheumatoid arthritis among anti-citrullinated protein antibodies positive asymptomatic individuals: A prospective observational study

Use of Baricitinib and Tocilizumab for the treatment of moderate to severe COVID-19 in hospitalized patients

PREDICTING CARDIOVASCULAR EVENTS IN PATIENTS WITH SPONDYLOARTHRITIS : 3 RISK ALGORITHMS Sacroiliac Joint MRI Abnormalities in Juvenile Spondyloarthritis: an Update of Definitions and Scoring of the OMERACT Juvenile Idiopathic Arthritis MRI Score COVID-19 INFECTION IN RHEUMATIC IMMUNE-MEDIATED INFLAMMATORY DISEASES. EPIDEMIOLOGICAL STUDY IN A SINGLE UNIVERSITY HOSPITAL EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start

Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) Predictive value of anti-interferon-inducible protein 16 antibodies for digital ulcers of systemic sclerosis The experience of a Rheumatology Unit during the COVID19 lockdown: Telemedicine allows a safe follow up of patients with rheumatic diseases Aminaphtone long-term treatment in Systemic Sclerosis Clinical course of new SARS-CoV-2 infection in children with rheumatic diseases: retrospective study of single pediatric rheumatology center

Assessment of interreader reliability in scoring patients with hand osteoarthritis and psoriatic arthritis by fluorescence optical imaging Long-term outcome in children with juvenile dermatomyositis from southern India Incidence and phenotype of antiphospholipid syndrome (APS) after preeclampsia Association of Rheumatoid Arthritis with Mortality in a cohort of Chronic Kidney Disease patients

MORTALITY RATE RELATED TO COVID - 19 IN RHEUMATIC AND MUSCULOSKELETAL DISEASES (RMDs) Berberine modulate lupus syndrome via the regulation of gut microbiota in MRL/Lpr mice Long-Term Outcomes of Children Born to Women with Rheumatoid Arthritis Anxiety, depression, fibromyalgia syndrome and pain intensity in patients with low back pain Comparing the ultrasonographic evaluation in patients with Japanese rheumatoid arthritis between Baricitinib and TNF antagonist therapy

Chondrocalcinosis as predictor of development of primary hyperparathyroidism: results of the follow-up observation.

Incidence and outcome of COVID-19 in routine rheumatology care: Data from a single outpatient center in Germany

Mortality of COVID-19 in patients with rheumatic diseases: comparison to the general population in México Noncoding RNA contribute to pathogenesis in primary gouty arthritis Visual function and quality of life: preliminary results from a pivotal cross-sectional study on one hundred patients with juvenile idiopathic arthritis-associated and idiopathic uveitis Mental Health Screening in Patients with Juvenile Idiopathic Arthritis Clinical features, prognostic factors, and outcome of Anti-MDA5 positive dermatomyositis with rapidly progressive interstitial lung disease: a multicenter study of 238 patients Infliximab For Vascular Involvement In Behçet Syndrome

Interleukin-4 activates eosinophils and CCR3-positive T helper cells migration to fascia and promotes fibrosis in eosinophilic fasciitis

Two-minute walk test as a simple and objective outcome measure in Idiopathic Inflammatory Myositis Relationship between involved joint for region and modified Health Assessment Questionnaire score in Japanese patient with rheumatoid arthritis Automated detection of sclerodermiform patterns using Capillary.io Spondilodiscitis without documented germ: what therapeutic management? Clinical features and outcome of 1054 patients with Systemic Sclerosis: an analysis of the Portuguese Reuma.pt registry for Scleroderma (Reuma.pt/SSc) Oral Status in patients with Rheumatoid Arthritis

Incidence and determinants associated with retransitioning from biosimilar SB4 to originator etanercept Clinical utility of screening tools in referral of patients with hand arthralgia to rheumatologists

Obesity rates and BMI are similar in age and sex matched rheumatoid arthritis, psoriatic arthritis and spondyloarthritis patients Osteoporosis in Psoriatic Arthritis: A 5 Year Prospective Study of an Outpatient Clinic Cohort A multi-predictor model to predict risk of scleroderma renal crisis in systemic sclerosis Combined Analysis of Metabolic and Transcriptomic Kidney Profiles of NZW/B-F1 Murine Lupus Uncovers Biological Mechanisms Preceding the Onset of nephritis

Short-term and mid-term efficacy of caudal epidural steroid injections in the management of degenerative sciatica

Trajectory clusters of radiographic progression in rheumatoid arthritis patients: associations with clinical variables

Myocardial infarctions, subtypes, locations and coronary atherosclerosis in SLE - a comparative study with matched controls

Outcome following COVID-19 infection in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis

Comparison of three different algorithms for the treatment of children with polyarticular JIA: the first year after diagnosis Comprehensive immune profiling of peripheral blood in psoriatic arthritis (PsA) patients: Expansion of intermediate monocytes and decreased T reg and CD8 T cells Relationship between paraoxonase-1 genotype, activity and major adverse cardiovascular events in patients with rheumatoid arthritis receiving tofacitinib NLRC4 AND FC-γ-R CROSSTALK ON CD1C+ DENDRITIC CELLS DIFFERENTIALLY CONTRIBUTES TO RHEUMATOID ARTHRITIS IMMUNOPATHOLOGY. ANNALYSIS OF PRO-INFLAMMATORY BIOMARKERS IN A POLYMYALGIA RHEUMATICA COHORT DURING THE ACUTE ONSET OF THE DISEASE

Evaluation of patients with (suspected) Behçet syndrome; diagnostic value of pathergy testing and ophthalmologic examination Non-Invasive Cutaneous Assessment Of Systemic Sclerosis- The New Outlooks Long-term efficacy and safety of canakinumab in patients with TRAPS (tumor necrosis factor receptor-associated periodic syndrome) - Interim analysis of the RELIANCE Registry Let’s take a look at the symphysis pubic area in spondylarthritis EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start serum Matrix Metaloprotinase 3 as a marker to discriminate subclinical disease activity from ultrasound defined remission in patients Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) with rheumatoid arthritis

Drug Retention Rate, Reasons for Discontinuation and Outcome of Infliximab Use in Behçet Syndrome Disconnect between treatment switches and disease activity state in early Psoriatic Arthritis

Differential clinical presentation between SLE ruphus patients and SLE non-rhupus patients: a case-control study

Echocardiographic findings in systemic lupus erythematosus patients and its relation to antibodies titers Impact of COVID-19 on initiation and renewal of biotherapies and targeted synthetic treatments Launching a New Relapsing Polychondritis ("RP") Program Raynaud’s Phenomenon in a Single Center Cohort of Turkish Children Foot Disorders and Falls risk in Older Persons Impact of the change in administration route of Tocilizumab and Abatacept, due to the COVID-19 lockdown on disease activity in patients with rheumatoid arthritis. Non-obese Rheumatoid arthritis patients with low Low-density lipoprotein have greater coronary atherosclerosis burden, plaque progression and cardiovascular event risk ASSOCIATION BETWEEN SERUM URATE AND INFLAMMATORY MARKERS IN YOUNG ADULTS: CROSS-SECTIONAL FINDINGS FROM A BIRTH COHORT

Effect of rheumatoid arthritis treatments on the intima-media thickness of supra-aortic trunks and on cardiovascular risk: Prognostic factors for aggravated vascular damage in Takayasu arteritis

The role of serum calprotectin in the diagnosis of inflammatory bowel disease in patients with Ankylosing spondylitis Myositis-specific antibodies in a retrospective single-center observational study

Characteristics of interstitial lung disease in patients with systemic sclerosis during long term follow-up, single center experience. The prevalence and clinical significance of ultrasonographic findings of distal medial hamstring tendons in patients with posteromedial knee pain The longitudinal associations of methotrexate and biologic use on hospital admission for rheumatoid arthritis patients in Western Australia population (1995- 2014) Biologic Treatment of Adult-Onset Still’s Disease: A Single Center Experience Catastrophizing in patients with psoriatic arthritis Catastrophizing in patients with spondyloarthritis Gout and Joint Replacements in the US

BIOLOGICAL THERAPY IN REFRACTORY NEUROBEHÇET’S DISEASE. MULTICENTER STUDY OF 42 PATIENTS Comparison of the frequency of detection of early signs of atherosclerosis in patients with calcium pyrophosphate crystal deposition disease and osteoarthritis.

Elevated expression of Tim-3 on neutrophils correlates with disease activity and severity of Ankylosing spondylitis Efficacy and Safety of Guselkumab, a Monoclonal Antibody Specific to the p19-Subunit of Interleukin-23, Through 2 Years: Results from a Phase 3, Randomized, Double-blind, Placebo-controlled Study Conducted in Biologic-naïve Patients with Active Psoriatic Arthritis

Treatment of ankylosing spondylitis with tumor necrosis factor-alpha inhibitors lowers the risk of renal function decline

Disease Severity and Outcomes Among Patients With Rheumatoid Arthritis Who Receive a Newly Approved Biologic: Real-World US Experience with Sarilumab from the ACR RISE Registry Symptoms characteristics of seropositive individuals at-risk for developing rheumatoid arthritis are versatile and comparable to those in people with early rheumatoid arthritis

Prevalence and risk factors for herpes zoster reactivation in 1542 patients with rheumatic diseases

Expression and clinical significance of autophagy-related genes in peripheral blood mononuclear cells of systemic sclerosis Infections and other adverse effects with biological therapies over the past 10 years

Descriptive study of the perceptions and preventive practices of postmenopausal tunisian women regarding osteoporosis Comorbidities associated to spondyloarthritis Follicular dendritic cell networks in minor salivary gland biopsies: a marker of disease activity at baseline and during the follow-up in Sjögren’s syndrome Ultra High‑resolution Ultrasound (UHFUS) of labial glands is a strong predictor of salivary gland histopathology in Sjögren's syndrome (pSS) Relationships between saliva immunoglobulins free light chains concentration and clinical, immunological, histological parameters in patient with primary Sjogren’s syndrome Vitamin D deficiency is mainly associated with severe lung involvement, longer disease duration and risk of death in elderly COVID-19 patients. TREATMENT ACCESS AND ADHERENCE DURING SOCIAL PREVENTIVE AND MANDATORY ISOLATION IN ARGENTINIAN PATIENTS WITH SPONDYLARTHRITIS AGGREGATED SURVIVIN BINDING AROUND HISTONE H3 EPIGENETIC MODIFICATIONS IN RISK LOCI ASSOCIATED WITH RHEUMATOID ARTHRITIS High Prevalence of Abdominal Obesity in Females with Axial Spondyloarthropathy Survival of giant cell arteritis patients in Slovenia NEUROSARCOIDOSIS. STUDY OF 30 PATIENTS FROM A SERIES OF 384 SYSTEMIC SARCOIDOSIS FROM A TERTIARY UNIVERSITY HOSPITAL A molecular signature response classifier predicts the likelihood of EULAR non-response to TNF inhibitor therapies in RA: results from a retrospective cohort analysis EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start Aesthetic impairment in patients with systemic sclerosis: a case control study using a semi-quantitative scale for body image Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) assessment. Laboratory ratios: a subrogate biomarker for detection of infection in SLE patients.

DIFFERENCES IN CLINICAL MANIFESTATION AND DISEASE ACTIVITY OF PEDIATRIC BEHÇET DISEASE: A CROSS- SECTIONAL COHORT COMPARISON BETWEEN TURKEY AND UNITED STATES Impact of joint destruction in the hands, the wrists and the ankles on the ultrasound assessment and the functional outcomes in rheumatoid arthritis in remission

Is nutritional follow-up in patients living with rheumatoid arthritis better with teleconsultation? - Experience before and after pandemic Evaluation of coping strategies in rheumatoid arthritis patients

CORRELATION BETWEEN EXPRESSION LEVELS OF MIR-155 AND MIR-223 IN SYNOVIAL FLUID AND ULTRASOUND SCORES FOR ACTIVE SYNOVITIS IN RHEUMATOID ARTHRITIS PATIENTS The course of coronavirus disease 2019 (COVID‑19) in patients with Sjogren’s syndrome treated with anti-CD20 monoclonal antibody (rituximab) The Relationship of Mast Cell Activation Syndrome and Hypermobile Ehlers-Danlos Syndrome in Hospitalized Patients in the United States

Challenges of Egyptian patients with Systemic Lupus Erythematosus during COVID-19 Pandemic

Application of the new ACR/EULAR 2019 classification criteria of Systemic Lupus Erythematosus to a inception, monocentric cohort of Undifferentiated Connective Tissue Diseases population at onset of the disease. Assessing relevant joints for monitoring CPPD disease: A Systematic Literature Review of imaging techniques by the OMERACT Ultrasound – CPPD subgroup

Optimizing a Referral Strategy for Patients with a High Probability of Axial Spondyloarthritis: the Role of Age and Symptom Duration

Reduction in monocyte count predicts sustained remission in rheumatoid arthritis patients treated with anti-TNF therapy Distribution of comorbidities in spondyloarthritis with regard to the phenotype and the presence of psoriasis: data from the ASAS- COMOSPA study. Psoriatic Disease – a heterogenous disease who needs a multidisciplinary care! EULAR Recommendation-based Quality Indicators (QIs) for Systemic Lupus Erythematosus (SLE): Elaboration, Final Set, Performance and Initial Validation Association of C-reactive protein and non-steroidal anti-inflammatory drugs with cardiovascular events in patients with psoriatic arthritis: a time-dependent Cox regression analysis. Obesity phenotypes in early rheumatoid arthritis

Reproducibility of a new automatic system (CAPILLARY.IO) in the analysis of Nailfold Capillaroscopy images Rheumatologic diseases as presentations of primary immunodeficiency diseases Optical spectral transmission (HandScan) in patients with psoriatic arthritis: first data on diagnostic value and associations with clinical and ultrasound disease activity markers. EPIDEMIOLOGICAL AND CLINICAL DIFFERENCES BETWEEN ANTI-MDA5 PHENOTYPES: DATA FROM A LARGE COHORT (MEDRA5) STUDY Long-term efficacy and safety of canakinumab in patients with Familial Mediterranean Fever (FMF) - Interim analysis of the RELIANCE Registry Prevalence of chondrocalcinosis in patients with inflammatory rheumatic diseases – frequently found in patients with rheumatoid arthritis and vice versa Central sensitization has major impact on quality of life in patients with axial spondyloarthritis Left ventricular geometric abnormalities associated with higher titers of rheumatoid factor and anti-cyclic citrullinated peptide antibodies in Rheumatoid Arthritis patients

Duration of starting bDMARDs are almost 3 times longer in RA patients than PsA patients: HUR-BIO real life results

The associated factors of ultrasonographic tenosynovitis in patients with rheumatoid arthritis in remission IMPACT OF A PRE-EXISTING INTERSTITIAL LUNG DISEASE ON SEVERITY OF COVID-19 IN PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES

The Journey of Patients from First Symptoms to Diagnosis of Systemic Lupus Erythematosus (SLE): An Observational Study

Risk factors for the development of diabetes mellitus in patients with gout according to a 6-year prospective follow-up study. Is active synovitis of metacarpophalangeal joints a neuropathic condition in rheumatoid arthritis patients? Results from a ultrasound study at level of the palmar digital nerves

A nationwide cohort study on clinical and laboratory manifestations in children with multisystem inflammatory syndrome (MIS-C) Do biologics improve fatigue in patients with rheumatoid arthritis?

Association of body fat mass and its distribution with disease activity, pain and disability in rheumatoid arthritis.

Telemedicine and Management of the patient affected by giant cell arteritis during the COVID-19 pandemic - TELEMACOV The impact of tumour necrosis factor-alpha inhibitor treatment on Wnt signaling inhibitors, noggin and cytokine levels in axial spondyloarthritis Preliminary results of long-term follow-up of the health status of patients using csDMARDs and b/tsDMARDS for rheumatic diseases during the COVID-19 pandemic Clinical characterization of Portuguese patients with Antisynthetase syndrome Treatment knowledge and preferences for Black people with hip and knee osteoarthritis: A Systematic Literature Review and Meta- analysis EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start

CONCORDANCE BETWEEN THE QUANTIFERON-TB GOLD IN-TUBE AND TUBERCULIN TEST FOR THE DIAGNOSIS OF Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) LATENT TUBERCULOSIS INFECTION IN PATIENTS WITH RHEUMATIC DISEASES

A CITIZEN SCIENCE APPROACH TO CAPTURE POOR MENTAL HEALTH RELATED TO COVID-19 IN RHEUMATIC PATIENTS AFTER CONFINEMENT DURING PANDEMIC IN ITALY The effect of M694V homozygosity on the carotid intima-media thickness and flow mediated dilatation in patients with FMF related amyloidosis Missing the window of opportunity: early arthritis clinics in times of COVID-19 Algorithm for differential diagnosis of arthropathies using osteoscintigraphy

Direct comparison of effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritis in real-world settings

The impact of non-persistence on resource utilization costs in immune-mediated rheumatic diseases

Fascial ultrasound: the context for dry needling trigger points in treatment of myofascial pain, postural imbalance

Clinical characteristics, imaging phenotype, and long-term outcomes of Takayasu arteritis patients with hypertension

Validation of the 2019 European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) classification criteria for systemic lupus erythematosus (SLE) in Hong Kong Chinese

Triple-positivity and Antinuclear Antibodies, insights on disease activity: a retrospective cohort study of Colombian RA patients Early factors associated with the initiation of treatment with biologics in patients with Axial Spondyloarthritis – results from a single centre retrospective cohort study.

Treatment of Uveitis Associated With Juvenile Idiopathic Arthritis: a Seven Years' Single-Centre Experience Development of a diagnostic algorithm for the differential diagnosis of interstitial lung disease: preliminary data from a multicenter retrospective case-control study Adverse drug reactions in tuberculosis and management Interleukin-37: associations of plasma levels and genetic variants in gout Infection risk among rheumatic patients receiving denosumab therapy: single centre experience

Favourable Short-Term Course of COVID-19 in Patients with Familial Mediterranean Fever Using Biologic Agents THE ROLE OF MUSCULOSKELETAL ULTRASOUND IN PREDICTING THE RESPONSE TO JAK INHIBITORS: RESULTS FROM A LARGE MONOCENTRIC COHORT Defining ear chondritis: Data from 685 patients with relapsing polychondritis

Comparison of carotid subclinical atherosclerosis and structural damage in axial spondylitis with and without concomitant inflammatory bowel disease. A multicenter study with 886 patients. . A multicenter study with 886 patients. TMT-based quantitative proteomics analysis of synovial fluid-derived exosomes in rheumatoid arthritis, axial spondyloarthritis, gout and osteoarthritis Procalcitonin in rheumatology High incidence and mortality of Pneumocystis jiroveci infection in anti-MDA5-antibody positive dermatomyositis: experience from a single center

Co prescription of Anti-acid therapy reduces the bio availability of mycophenolate mofetil in systemic sclerosis patients Both spondyloarthritis and psoriatic arthritis patients have strong family histories Clinical and radiological features of seropositive psoriatic arthritis Lupus nephritis: histological features and long term outcomes in a large single-centre cohort The role of urinary tract infections as a source of osteoarticular infections in a rheumatology department during the 2010-2020 period: a retrospective study. COVID-19 in patients with systemic sclerosis: one rheumatology center experience

MONOGENIC AUTO-INFLAMMATORY DISEASES IN ADULTS IN THE PRACTICE OF A RHEUMATOLOGIST

The association between bariatric surgery and Dupuytren disease: a cohort study from Swedish nationwide healthcare registries

Reactogenicity of SARS-CoV-2 Vaccines in Patients with Autoimmune and Inflammatory Disease Could be interstitial myocarditis a feature of the antisynthetase syndrome?

Anti-MDA5 and antisynthetase antibodies screening in severe SARS-CoV-2 pneumonia. Be aware of false positive results. Comparison of numerical rating scale (NRS) and visual analogue scale (VAS) in the patient reported outcome measures of 3VAS and 4VAS in Psoriatic Arthritis The effect of arthritis treatment on the course of rheumatoid arthritis-associated interstitial lung disease focusing on biologic DMARDs: from a prospective cohort study (Part 5) Developing a Tool to Measure the Learning Curve: Enthesitis Ultrasound in Psoriasis Arthritis

COVID-19 in Italian patients with rheumatic autoimmune systemic diseases: results of a nationwide survey study

Aberrant Th17 cells expansion and risk factors in ankylosing spondylitis patients complicated with cardiovascular events

The association between social stressors and disease remission among men and women with early rheumatoid arthritis

Comparison of the efficacy and safety of original and biosimilar adalimumab molecules in childhood rheumatic diseases

Regulation of intestinal flora restores immune balance in patients with undifferentiated spondyloarthritis EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start Usefulness of synovial biopsy in the differential diagnosis and as possible predictor of response to treatment in juvenile idiopathic Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) arthritis

Latent tuberculosis infection in rheumatic diseases: a real-life study of three Apulian centres. Data from BIOPURE registry ANTIPHOSPHOLIPID ANTIBODIES AND COVID-19: TREND OVER TIME

The impact of anti-Ro antibodies in pregnant patients with Systemic Lupus Erythematosus and Sjögren’s Syndrome

Asymptomatic Enthesitis and Dominant Side Related Patterns in Spondyloarthritis – The Role of Ultrasonography in Everyday Practice

Clot lysis time predicts recurrent digital ulcers in systemic sclerosis after one year of follow-up: A nested case-control study Local adaptation of recommendation-based materials for shared decision-making and management of comorbidity in rheumatoid arthritis

Treatment survival on biologics in patients with axial spondyloarthritis – data from Moscow Unified Arthritis Registry (MUAR) FERTILITY AND PREGNANCY OUTCOMES IN TAKAYASU’S ARTERITIS

Serum uric acid to creatinine ratio is associated with urinary uric acid excretion in patients with gout Spinal location of tuberculosis: what has changed over the last years? Number and co-expression of TNF receptors type 1 and 2 on immunocompetent cells are associated with stability of remission in rheumatoid arthritis patients Investigation on the effect and mechanism of abnormally activated CD8+ T cells from bone marrow on hematopoietic stem cells in patients with systemic lupus erythematosus Changing expression profiles of long noncoding RNAs, miRNAs, mRNAs and circular RNAs in labial salivary glands of primary Sjögren’s syndrome (pSS) Fibroblasts are not just fibroblasts - clear differences in ECM production between dermal and lung fibroblasts in response to growth factors Sustained 2-year remission of the disease in a clinic of excellence in rheumatoid arthritis. Experience of the clinical registry in Colombia. The formula to predict tacrolimus concentration according to genotyping of CYP3A5 is useful for effective treatment in interstitial lung disease with dermatomyositis HYPOGAMMAGLOBULINEMIA IS A SIGNIFICANT RISK FACTOR FOR MORTALITY IN PATIENTS WITH ANCA ASSOCIATED VASCULITIS AND COVID-19 Improved survival in Systemic Sclerosis patients during last decade: current findings and comparison with different previous Italian cohorts. Dose-dependent Relationship Between History of Dental Caries And Increased Risk of Newly-onset Systemic Lupus Erythematosus: A Nationwide Population-Based Cohort Study The patient global assessment (PGA) of disease activity collects different information in early compared to established rheumatoid arthritis. Predictors of Endothelial Dysfunction in Ankylosing Spondylitis

SEVERE RESPIRATORY INFECTIONS IN RHEUMATOID ARTHRITIS PATIENTS WITH BIOLOGIC THERAPY. COMPARATIVE STUDY BETWEEN VACCINATED AND NON VACCINATED PATIENTS. EULAR RECOMMENDATIONS ON GIANT CELL ARTERITIS IN REAL LIFE Single dose tocilizumab pharmacokinetics in glucocorticoid pre-treated COVID-19 patients during cytokine storm syndrome hyperinflammatory episode: less is more Self- and shared-management interventions for children, young people, and families living with rheumatic and musculoskeletal diseases: An integrative review

Does time to remission differ depending on route of administration of Methotrexate in an Early Arthritis Treat to Target (T2T) cohort? How does obesity influence the features of knee osteoarthritis ?

Detection of the gene expressions in peripheral blood involved in the progression of pulmonary vessel disease at the subclinical stage of pulmonary hypertension associated with systemic sclerosis.

Infectious Risk During Biologic Therapy For Inflammatory Rheumatic Diseases: Data From The Tunisian BINAR Registry

ASSESSMENT OF DAREA AND MODIFIED DAREA IN AN ARGENTINIAN-GUATEMALAN REACTIVE ARTHRITIS COHORT Rheumatoid arthritis is an inflammatory disease with a high cardiovascular risk. WHEN DO THE ACTIVE SACROILIITIS MRI FINDINGS LOSS IN ANKYLOSING SPONDYLITIS? A RETROSPECTIVE, CROSS- SECTIONAL, OBSERVATIONAL STUDY APLs-associated Retinal Vasculopathy as a Presentation of Thrombotic Microangiopathy The Enhanced Liver Fibrosis (ELF) score as a biomarker of skin fibrosis in systemic sclerosis

Safety of anakinra in patients with cryopyrin associated periodic syndromes (CAPS) using a graduated pre-filled syringe

ROLE OF SYSTEMIC AUTOINMUNE CONDITIONS IN HOSPITAL ADMISSIONS RELATED TO COVID-19 ASSESSMENT OF EMOTIONAL WELL-BEING IN RHEUMATIC PATIENTS DURING COVID-19 LOCKDOWN THROUGH A WEB- BASED SURVEY APPROACH Circulating Exosomes Promote Lupus Nephritis in MRL-lpr Mice A Cohort Study On The Risk of Developing Obstructive Sleep Apnea, Temporomandibular Joint Disorders and Craniofacial Deformities In Patients With Juvenile Idiopathic Arthritis Adiponectin induces synovial angiogenesis in rheumatoid arthritis through metabolic remodeling Psoriatic arthritis with hyperuricemia: more peripheral, destructive and challenging to treat Molecular profiling of radiographic axial spondyloarthritis patients reveals an association between innate and adaptive cell populations and therapeutic response to adalimumab EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start

Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) Evaluation of the effect of mTOR expression on the clinical manifestations of knee osteoarthritis in obese and normal weight patients. Post-immunization with collagen V confers a disadvantageous immune matrices microenvironment for early lung fibrosis in a SSc mouse model Long-Term Clinical Outcomes of Patients with Lupus Nephritis treated with an Intensified B-Cell Depletion Protocol: A Prospective Study Factors associated with severe SARS-CoV-2 infection in patients with inflammatory rheumatic diseases in Madrid: results from REUMA-COVID SORCOM registry

Ultrasonography of the median nerve in patients with rheumatoid arthritis under suspicion of carpal tunnel syndrome Current registries in PsA do not well reflect the profiles of patients with PsA because they originate in similar countries : a systematic literature review of 27 registries, or 16183 patients WORK ABSENCE DUE TO MUSCULOSKELETAL SYMPTOMS IN PATIENTS AT-RISK OF RHEUMATOID ARTHRITIS IS COMPARABLE TO THOSE WITH ESTABLISHED DISEASE Antiphospholipid related large vessel lesions: not only thrombosis LONG TERM OUTCOME OF MULTIPLE ULTRASOUND GUIDED SUPRASCAPULAR NERVE BLOCK IN TREATMENT OF FROZEN SHOULDER IN DIABETIC PATIENTS COVID-19 from the patients’s perspective: preliminary results of online survey

Subclavian arteries involvement in patients with giant cell arteritis: do we need a modified Halo Score? INCREASED BDNF LEVELS AS A PREDICTOR OF CENTRAL SENSITIZATION IN PATIENTS WITH ANKYLOSING SPONDYLITIS Does experience in Systemic Lupus Erythematosus influence the Physician Global Assessment scoring? A cross-sectional study on two European cohorts. Identifying Mechanisms Underlying the Association between Rheumatoid Arthritis and Periodontitis Using in Silico Analysis of Canonical Pathways

Anti-IL-1 Therapies in Colchicine-Resistant or İntolerant Patients with Familial Mediterranean Fever: Single Center Experience

Performances of Different Classification Criteria for Systemic Lupus Erythematosus in a Single Center Cohort from Turkey HYDROXYCHLOROQUINE CARDIOTOXICITY: A CASE-CONTROL STUDY COMPARING PATIENTS WITH COVID19 AND PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Clinical presentation and outcomes of the antiphospholipid syndrome (APS) in southern Chinese patients: the Hong Kong APS registry

Correlation of Peripheral CD4+GranzB+CTLs with Disease Severity in Patients with Primary Sjögren’s Syndrome A cohort study of COVID-19 related multisystem inflammatory syndrome in children and adolescents from multiple tertiary care centres in south India The impact of the COVID-19 pandemic on Physical Functioning and Mental Wellbeing in 824 patients with Rheumatic Disease over 8 months: Physical Functioning Declines The discordance between patient-reported and clinical/biological outcomes could help in predicting future disease impact in patients with rheumatoid arthritis

Algorithm identifying chronic inflammatory diseases treated by biotherapy and/or targeted synthetic treatments in outpatient care in France: feasibility, preliminary results, and impact of COVID-19 Influence of demographic and disease related factors on efficacy of infliximab or golimumab in rheumatoid arthritis. A meta-analysis on randomized placebo- controlled trials.

SKIN LESIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME Musculoskeletal variant of Familial Mediterranean Fever May Have More Severe Disease

BASELINE FACTORS ASSOCIATED WITH LUPUS FLARES: A POST-HOC ANALYSIS OF PATIENTS WITH MODERATE TO SEVERE ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS ENROLLED IN A 48 WEEK PHASE II RANDOMIZED CLINICAL TRIAL Engineered glove to evaluate the speed of the hands’ movements in rheumatoid arthritis Assessment of risk factors for hospitalization of autoimmune and rheumatic disease patients with COVID-19 – A single centre observational study.

Performance of major salivary gland ultrasound for the diagnosis of Sjögren’s Syndrome in clinical practice Anti-TNF drugs and cardiovascular events in patients with spondyloarthritis. Efficacy of intra-articular corticosteroid injections in knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials.

COVID-19 in patients with rheumatic diseases: survey-based assessment of the risk of hospitalization

Transcranial electrical stimulation is safe and efficient in patients with systemic autoimmune myopathies

Validity and psychometric characteristics of the Psoriatic Arthritis Quality of Life (PsAQoL) Questionnaire in Turkish population Macrovascular dysfunction and its clinical implication in systemic sclerosis Daily Activity Impairment is Mediated by Both Oral Dryness and Oral Health Related Quality of Life in Patients with Primary Sjögren’s Syndrome

PREDICTORS OF END STAGE RENAL DISEASE IN THE RENAL BIOPSY PROVEN LUPUS NEPHRITIS Impact of COVID-19 pandemic on disease activity and emotional well-being among Rheumatoid Arthritis patients: a telemedicine study

Predictive factors for response to treatment in a long-term cohort of patients with juvenile idiopathic arthritis-associated uveitis EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start

Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) Disorders of urodynamics and parenchyma concentration function in patients with arterial hypertension and gout

A systematic review of international guidelines regarding the role of radiography in the diagnosis of osteoarthritis

EFFECTS OF ACUTE EXERCISE ON SERUM BDNF LEVEL IN PATIENTS WITH RHEUMATOID ARTHRITIS Catastrophizing in patients with rheumatoid arthritis Clinical characteristics of the pulmonary artery involvement in patients with Behçet’s syndrome: A single-centre experience of 61 patients

COVID-19 IN PATIENTS WITH RHEUMATIC DISEASES ON CHRONIC USE OF HYDROXYCHLOROQUINE IN A LARGE BRAZILIAN COHORT – A 24-WEEK PROSPECTIVE STUDY Arthritis in adult IgA vasculitis The impact of age on discontinuation of biologic DMARDs in patients with Rheumatoid Arthritis Some parameters of endothelial function in patients with idiopathic avasclar necrosis Retrospective analysis of pregnancy outcomes in patients with obstetric antiphospholipid syndrome (OAPS), non-criteria OAPS (NC- OAPS) and antiphospholipid carriers

The effect of platelet inhibitors on digital ulcers in systemic sclerosis - a derivation and validation EUSTAR study

Predictors of durable clinical response to tofacitinib 11 mg once daily with or without methotrexate in patients with rheumatoid arthritis: post hoc analysis of data from a Phase 3b/4 methotrexate withdrawal study

MONITORING C3 AND C4 VARIATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS PREGNANCIES IS USEFUL TO RECOGNIZE COMPLICATIONS. DATA FROM 2 ITALIAN CENTERS

A Reliability Exercise Using Consensual Definitions for the Ultrasonography of the Shoulder in Rheumatoid Arthritis Baseline calprotectin and visfatin levels predict radiographic spinal progression after 2 years in ankylosing spondylitis patients on TNF inhibitor therapy

RHEUMATOID ARTHRITIS AND ORAL MICROBIOME: PREDICTORS OF DISTURBANCES AND ITS IMPLICATIONS. RESULTS FROM A COHORT AT TREATMENT WITH cs/b/tsDMARD

Hepcidin is potential biomarker to distinguish between iron deficiency anemia and anemia of inflammation in rheumatoid arthritis IMMUNE-MEDIATED DISEASES (IMID) AND CORONAVIRUS DISEASE 2019 (COVID-19): RESULTS FROM AN OBSERVATIONAL RETROSPECTIVE MULTICENTER STUDY

Young versus Late-Onset Rheumatoid Arthritis: a prospective 12 month-follow-up cohort study in an early arthritis cohort Pulse pressure as an indicator of subclinical atherosclerosis in Rheumatoid Arthritis

SURVIVAL OF THE FIRST COURSE OF BIOLOGIC OR JAK INHIBITOR IN RHEUMATOID ARTHRITIS: ASSOCIATION WITH THE CHOICE OF AGENT AND CONCOMITANT CONVENTIONAL SYNTHETIC DMARDS

Early infectious risk in patients with newly-diagnosed anti-neutrophilcytoplasmic antibody-associated vasculitis according to the remission-inductiontherapy: a French monocentric retrospective study including 145 patients

Differences in proinflammatory and lipid profile between psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis The comparative 3-year retention rate of targeted-synthetic and biologic drugs for rheumatoid arthritis: real-life data from the Italian GISEA Registry An investigation of joint inflammation defined by comprehensive ultrasound assessment and pain sensitisation in patients with active RA

Hyperlipidemia in psoriatic disease: higher prevalence in psoriatic arthritis and inverse association with systemic therapy Comparison of Injection Site Reactions and Injection Site Erythema between YLB113 and etanercept reference product from Phase 3 active comparator study (Study No. YLB113‑002) Demographics, comorbidities, and renal function of uncontrolled gout patients who received pegloticase: finding from a large US claims database

Differences in treatment satisfaction, patient preferences, and treatment patterns between European, South American, and Japanese patients with suboptimally controlled rheumatoid arthritis: A subgroup analysis of the SENSE study

The Efficacy and Safety of Tocilizumab in Patients With Giant Cell Arteritis: A Systematic Review and Meta-Analysis The Different Subtypes of Giant Cell Arteritis by Ultrasound: Results from a fast-track clinic Effect of Upadacitinib on Reducing Pain in Patients With Active Ankylosing Spondylitis and Inadequate Response to Nonsteroidal Anti- inflammatory Drugs Evaluation of Response to Pneumococcal Vaccination in Patients with Rheumatoid Arthritis Receiving Upadacitinib: Results from a Phase 2 Open-Label Extension Study

Voluntary wheel running model in mice to mechanically stimulate the enthesis of the Achilles tendon Brucellar spondylodiscitis: Clinical and magnetic resonance imaging findings ULTRASOUND FOR PANNICULITIS. CAN INTERLEUKIN 33 (IL-33) BE CONSIDERED A VALUABLE BIOMARKER IN THE EARLY STAGES OF SYSTEMIC SCLEROSIS? ANALYSIS OF A MONOCENTRIC COHORT JIA patients do not have more osteoporosis than healthy age and sex-matched controls but lower bone mass density is found at total hip and cortical compartment Analysis of 5-year Hospitalization data of Patients with Systemic Lupus Erythematosus: Damage is a risk factor for frequent and longer stays EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start Upadacitinib as Monotherapy and in Combination with non-biologic DMARDs for the Treatment of Psoriatic Arthritis: Subgroup Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) Analysis from Two Phase 3 Trials

Association between antibiotic use and knee pain and function in OA: data from the Osteoarthritis Initiative Use of telemedicine for follow-up of SLE patients with nephritis in the COVID-19 outbreak (“TeleSLE”): the 6-month results of a randomized controlled trial Serum biomarkers before and after a six months structured weight loss intervention in patients with psoriatic arthritis and obesity compared with controls. Filgotinib-treated rheumatoid arthritis patients with high baseline neutrophil-to-lymphocyte ratio show better clinical response rates and patient-reported outcomes

Conduction and Rhythm Disorders among Patients with Systemic Sclerosis: A US Population Based Study Autoimmune liver disease in anticentromere antibody positive primary Sjogren’s syndrome De novo lupus nephritis following the introduction of Belimumab. Fibrocytes in Early and Longstanding Rheumatoid Arthritis: A 6-month trial with repeated synovial biopsy, imaging, and lung function test. Predictors of hospitalization in patients with systemic lupus erythematosus: a 10-year cohort study of 398 patients from a tertiary centre

Identifying potential classification criteria for calcium pyrophosphate deposition disease (CPPD): results from the initial phases Costs and factors affecting health service utilisation in patients with gout: a longitudinal, population-level linked data study in Western Australia.

UNDERSTANDING PRESCRIPTION BEHAVIOR ACROSS HEALTHCARE PROFESSIONALS IN TREATING KNEE OSTEOARTHRITIS BEFORE AND DURING THE 2020 COVID-19 PANDEMIC Cytokine Biomarkers in Common Low Back Pain Risk of serious infections in offspring exposed in utero to ustekinumab or Hyperinflammation and clinical outcomes for patients with systemic rheumatic diseases hospitalized for COVID-19: A comparative cohort study Blood-derived DNA methylation epi-signatures associated with Ankylosing Spondylitis

Low Incidence of Gastrointestinal-related and Overall Serious Adverse Events Among Guselkumab-treated Patients: Pooled Analyses of VOYAGE 1 & 2 and DISCOVER 1 & 2 Through 1-Year

A single dose of zoledronate induces modifications of serum VEGF in osteoporotic postmenopausal women.

SPECIFIC MITO-NUCLEAR INTERACTIONS AND mt16519C VARIANT AS PREDICTIVE BIOMARKERS FOR THE RAPIDLY PROGRESSIVE OSTEOARTHRITIS OF THE KNEE. DATA FROM THE OSTEOARTHRITIS INITIATIVE.

Risk factors of non-protective levels of antibodies to vaccines in patients with juvenile idiopathic arthritis. Body composition and frequency of sarcopenia in patients with systemic sclerosis Peripheral arthritis and higher disease activity lead to more functional impairment in axial spondyloarthritis: longitudinal analysis from ESPAXIA

Quality of life in chronic back pain patients, a 2-year comparison between patients with and without a diagnosis of axial spondyloarthritis: Data from the SpondyloArthritis Caught Early Cohort Self-reported SARS-CoV2 testing and COVID-19 disease in patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis in a Swiss observational cohort Extracellular matrix protein turnover markers are associated with axSpA– a comparison with control subjects with or without pelvic, buttock or back pain

Impact of Upadacitinib or Adalimumab as Initial Therapy on the Achievement of 48-Week Treatment Goals in Patients with Rheumatoid Arthritis and Inadequate Response to Methotrexate: Post hoc Analysis of a Phase 3 Study Geographic Variation of Efficacy in the Filgotinib Rheumatoid Arthritis Program

IN SPONDYLOARTHRITIS PATIENTS THE PRESENCE OF COMORBIDITIES IS AN INDEPENDENT PREDICTOR OF INSUFFICIENT RESPONSE TO THERAPY WITH BIOLOGIC AGENTS AND TREATMENT DISCONTINUATION Efficacy of ixekizumab through 52 weeks for improving peripheral joint involvement among patients with radiographic-axial spondyloarthritis Cardiovascular risk status and obesity in gout compared to healthy Mexican subjects: a case-controls study with a propensity score- matched analysis.

RITUXIMAB THERAPY IN THE INTERSTITIAL LUNG DISEASE OF RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW.

The Effect of Filgotinib on Enthesitis: 100-week Data from an Open-label Extension Study in Patients with Active Psoriatic Arthritis

More Frequent and Earlier Hip Involvement in Spondyloarthritis Associated with Familial Mediterranean Fever

Preliminary findings of the PROTECT clinical trial: pegloticase efficacy and safety in kidney transplant recipients

Dual Energy CT Has Prognostic Value in Gout Beyond Standard Clinical Measures: A Best Evidence Synthesis Physician and Patient Reported Effectiveness Outcomes are similar in Tofacitinib and TNF Inhibitors in Rheumatoid Arthritis Patients: Data from a Rheumatoid Arthritis Registry in Canada ULTRASOUND ASSESSMENT OF SUB-CLINICAL HAND JOINT SYNOVITIS: A COMPARATIVE STUDY BETWEEN PSORIATIC AND RHEUMATOID ARTHRITIS COVID-19 vaccine hesitancy among rheumatology patients receiving influenza vaccine EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start Performance of 2019 EULAR/ACR classification criteria for Systemic Lupus Erythematosus in a pediatric population – a multicenter Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) study

Higher serum uric acid is associated with increased risk of obesity in Chinese adults: A longitudinal data analysis Musculoskeletal manifestations in a cohort of 234 inflammatory bowel disease patients Rheumatologist and patient perspectives on implementing cardiovascular risk prevention in the management of psoriasis: A qualitative study

Risk Factors for Polyarticular Gout Flares—Analysis of a Longitudinal Online Gout Follow-Up Study

THE IMPACT OF COVID-19 QUARANTINE ON MENTAL HEALTH OF PATIENTS WITH FIBROMYALGIA The therapeutic target is reached more often in RA patients starting TNF inhibitors with moderate activity than with high disease activity –an analysis from the ATTRA registry Lifestyle and Mood Changes in AxSpA Patients During the Quarantine Period

Responsiveness of spinal mobility measurements in axial spondyloarthritis using conventional and advanced metrology: a pilot study Patient Characteristics & Clinical Features Associate With Health-Related Quality of Life in Bio-naïve Patients With Active Psoriatic Arthritis Through Week 24 of the DISCOVER-2 Study Prevalence of sleep disturbance in patients with ankylosing spondylitis within the Australian Clinical Setting (ASLEEP study): A Real- World Observational Study using the OPAL Dataset.

Epidemiology and trends in survival of systemic sclerosis in Olmsted County: A population-based study (1980-2018) Effect of emotional triggers on the frequency of PFAPA attacks - a multicenter study

Biosimilar infliximab therapy in rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: a long-term follow-up study on infliximab-naïve patients and patients switched from the originator to the biosimilar CT-P13

Diagnostic delay in axial spondyloarthritis: results from the National Early Inflammatory Arthritis Audit

Importance of body mass measurement and the grip strength test to predict falls in patients with rheumatoid arthritis

Effect of Argentine tango practice on total physical activity time in patients with chronic inflammatory rheumatism: a pilot study. Visual ischemia during relapse and follow-up of giant cell arteritis: a systematic review Incidence, prevalence, and mortality of chronic periaortitis: a population-based study Meaningful Improvement and Worsening in Patients Who Do Not Achieve LDA and Switch Therapy to a New Biologic or Targeted Therapy: Results from the CORRONA Registry COMORBID INFECTIONS IN PATIENTS WITH SPONDYLOARTHRITIS. Chronic low back pain: therapeutic strategies and clinical outcomes in a military population Ankylosing Spondylitis in West African patients: A series of 37 cases reported in Togo Rheumatology patient attendance to the paediatric emergency department

Achievement of Partial Remission and Inactive Disease in Upadacitinib-Treated Patients with Ankylosing Spondylitis The development and validation of a risk stratification questionnaire to screen for medication related Osteonecrosis of the jaw risk in osteoporotic patients

Relationship between Changes in Lipid Levels and Improvement in Disease Activity Outcomes in Patients with Rheumatoid Arthritis Receiving Upadacitinib Treatment: Pooled Analysis of Data from Two Phase 3 Studies

Characteristics and outcomes in a real-world cohort of rheumatoid arthritis patients with COVID-19

Differences in drug survival between Originator and Biosimilar products among first users of each molecule

Association Between Pain Severity and Healthcare Utilization in an Osteoarthritis Population: An 18-Year Retrospective Cohort Study

Prevalence of rheumatoid cachexia and its association with serum fetuin-A levels in Caucasian patients with rheumatoid arthritis. Geographic Variation of Safety in the Filgotinib Rheumatoid Arthritis Program Responsiveness of conventional, semi-automatic and full-automatic methods to quantify marrow bone edema lesions in MRI of axial spondyloarthritis patients: a pilot study. Efficacy of tofacitinib on dactylitis in individual digits in patients with active psoriatic arthritis Relationship between psychological factors and measures of rheumatoid arthritis activity Presence and Associated Factors of Fatigue in Patients in Patients with Axial Spondyloarthritis. Results from the European Map of Axial Spondyloarthritis (EMAS).

Monomeric C Reactive Protein (mCRP) Regulates Inflammatory Responses in Human and Mouse Chondrocytes

Review of the impact of COVID-19 pandemic on Rheumatology Services at a large tertiary care centre in Wales, UK Anatomical Locations and Correlates of Calcium Pyrophosphate Crystal Deposits of the Spine – Pathologic Examination of 77 Surgical Cases "Extra"- criteria antiphospholipid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus (preliminary data) Relationship of Anifrolumab PK With Efficacy and Safety in Patients with SLE Lorecivivint (SM04690), an Intra-articular, Small-Molecule CLK2/DYRK1A Inhibitor That Modulates the Wnt Pathway, as a Potential Treatment for Meniscal Injuries

Are there gender differences in axial spondyloarthritis: data from a Portuguese spondyloarthritis cohort

MEDITERRANEAN DIET IN AXIAL SPONDYLOARTHRITIS: A NUTRITIONAL INTERVENTION STUDY EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start Efficacy of Upadacitinib in Patients with Psoriatic Arthritis Stratified by Baseline Skin Severity: A Subgroup Analysis of Two Phase III Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) Trials

The assessment of fracture risk and osteoporosis rate among patients over 50 years old undergoing medical rehabilitation LARGE VESSEL-GCA: A DIAGNOSTIC CHALLENGE ANKLE ARTHRITIS IN JUVENILE IDIOPATHIC ARTHRITIS: DON’T MISS TENOSYNOVITIS. CLINICAL AND SONOGRAPHIC FEATURES OF ANKLE TENOSYNOVITIS IN JIA. Fluorescence optical imaging (FOI) detects subclinical inflammation in hands of patients diagnosed with fibromyalgia syndrome and other rheumatic diseases Impact of Concomitant Glucocorticoids on the Clinical Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: An Ad Hoc Analysis of Data from Three Phase 3 Studies SUICIDAL BEHAVIOUR IN SLE PATIENTS: A SYSTEMATIC LITERATURE REVIEW

Factors Associated with Switching from one anti-TNF Agent to Another Anti-TNF, or IL17 Agent in Patient with Ankylosing Spondylitis Idiopathic, rheumatoid arthritis and diabetes mellitus associated carpal tunnel syndrome: evaluation of the depth of the carpal tunnel by ultrasonography Efficacy of Upadacitinib in Patients with Psoriatic Arthritis Stratified by Number of Prior Biologic Disease-modifying Anti-rheumatic Drugs Concomitant Use of Statins in Filgotinib-Treated Patients with Rheumatoid Arthritis Presence of tophi is associated with a rapid decline in the renal function in patients with gout Cardiovascular risk in different clinical variants of spondyloarthritis

Response to Sequential Lines of Biological Therapy in Psoriatic Arthritis: A single centre cohort study

Agreement between Vertebral fracture Assessment and radiographic scans for the diagnosis of vertebral fracture

Different clinical characteristics of IgG4-RRD patients and non-IgG4-RRD patients: a large Chinese cohort study Correlation between skin involvement, joint involvement and enthesitis in patients with active psoriatic arthritis: post-hoc analysis of EQUATOR/EQUATOR2 COVID-19 ACROSS RHEUMATOLOGY: A BIBLIOMETRIC STUDY

Evidence based practice: What is the evidence that British Society for Rheumatology guidelines are evidence based? Salivary gland ultrasonography and the Clinical features using ESSDAI in patients of early-onset versus late-onset with primary Sjögren's syndrome Comparison of carotid subclinical atherosclerosis and structural damage in axial spondylitis with and without concomitant anterior uveitis. A multicenter study with 886 patients.

Decline in forced vital capacity (FVC) in subjects with systemic sclerosis-associated interstitial lung disease (SSc-ILD) in the SENSCIS trial versus hypothetical reference subjects without lung disease The long-term clinical course of muscular vasculitis depending on the anti-neutrophil cytoplasmic antibody status: a retrospective observational study Autoimmune diseases associated with chronic liver diseases Diagnostic Value of High-Resolution peripheral quantitative computed tomography compared to conventional radiography for detecting erosive disease in Rheumatoid Arthritis. Usual interstitial pneumonia during rheumatoid arthritis: Prevalence and associated factors Assessment of the COVID-19 Pandemic from the Perspective of People with Rheumatic Musculoskeletal Diseases in Europe. Results from the REUMAVID Study (Phase 1)

Patient-Reported Impact of Axial Spondyloarthritis on Working Life. Results from the Spanish Atlas

Correlates of testing positive for SARS-CoV-2 in patients with rheumatic ad musculoskeletal diseases Ixekizumab improves signs, symptoms and quality of life of ankylosing spondylitis in patients irrespective of HLA-B27 status: pooled results from the COAST-V and COAST-W trials

Gout patients in remission, and their perspectives on urate lowering therapy treatment stop or continuation strategies IMPLEMENTATION OF THE OMERACT PSAMRIS IN A PHASE IIB, RANDOMISED PLACEBO-CONTROLLED STUDY OF ABATACEPT IN PSORIATIC ARTHRITIS Efficacy, Safety and Characteristics of Iguratimod-based Therapy in the Treatment of UA, ERA and RA Patients for 24 Weeks: A Prospective Cohort Study Panniculitis as a manifestation of an autoimmune/autoinflammatory disease

Pain in children with Juvenile Idiopathic Arthritis treated to target: 24 month results from a randomised trial Using Hip Structural Analysis Measurements to Predict Fracture in Rheumatoid Arthritis Mental health outcomes among health care workers during the coronavirus-19 pandemic Prevalence and Severity of Stress at Home among patients with Rheumatoid Arthritis: single centre results from the PRIME registry cohort Epidemiology of Cocaine and hallucinogen use disorder hospitalizations in Rheumatic Diseases Safety of ixekizumab in patients with psoriatic arthritis: an integrated analysis of 4 clinical trials

Factors associated with fertility outcomes in women with Systemic Lupus Erythematosus: a systematic review.

Psychiatric disorders in patients with different phenotypes of neuropsychiatric systemic lupus erythematosus (NPSLE) Early Identification of Axial Spondyloarthritis in a Multi-Ethnic Asian Population EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) BILAG-2004 Index Active Disease predicts development of damage Prevalence and Associated Factors of Sleep Disorders in Patients with Axial Spondyloarthritis. Results from the European Map of Axial Spondyloarthritis (EMAS) Prevalence, incidence and antirheumatic drug use in psoriatic arthritis (PsA) in Norway

Personal Experiences with Diagnostic Delay Among Axial Spondyloarthritis Patients – A Qualitative Study

The serum iron level might be useful in determining the severity of malnutrition in patients with rheumatoid arthritis A short delay in arthritis care is associated with higher disease activity - lessons from the coronavirus disease 19 (COVID-19) pandemic. IMMUNOGENICITY AND SAFETY OF 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN PATIENTS WITH SPONDYLOARTHRITIS. Comparison of FMF clinical features between Turkish and Crimean Tatar children.

How HLA B27 prevalence in the population influence on features of juvenile idiopathic arthritis: data from Sakha Republic (Yakutia).

A New questionnaire and Score (MISA) for Assessing Methotrexate Intolerance in Rheumatoid Arthritis

Rapid and Concurrent Improvements in Patient-Reported Outcomes of Rheumatoid Arthritis with Baricitinib in RA-BEAM Association between individual and country-level socioeconomic factors and health outcomes in axial and peripheral spondyloarthritis: analysis of the ASAS perSpA study

The relationship between sedentary behavior and sleep in Rheumatoid Arthritis: a cross-sectional study INCONSISTENCY OF THE DEGREE OF CARDIOVASCULAR RISK WHEN ASSESSED USING DIFFERENT INDICES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS

Guselkumab-Treated Patients With Psoriatic Arthritis Achieved Clinically Meaningful Improvements in General Health Outcomes Measured With PROMIS-29 Through 52 Weeks: Results From the Phase 3 DISCOVER-1 Trial

The relevance of osteoporosis diagnosis and treatment for doctors working in the field of physical and rehabilitation medicine Importance of lateral spine view in DXA bone densitometry in patients with spondyloarthritis ABATACEPT IN MONOTHERAPY VERSUS COMBINED IN INTERSTITIAL LUNG DISEASE OF RHEUMATOID ARTHRITIS. MULTICENTER STUDY OF 263 CAUCASIAN PATIENTS Risk factors of total hip arthroplasty in juvenile arthritis with hip involvement Enhancing osteoporosis management: The contribution of FRAX® and VFA in Tunisian women

Self-protection strategies, health behavior and disease activity during the first wave, re-opening and second wave of the COVID-19 pandemic in >7000 Danish patients with inflammatory arthritis

Behçet`s disease and course of pregnancy - Results from the nationwide pregnancy register RevNatus White matter hyperintensities lead to reduced psychomotor speed in patients with systemic lupus erythematosus and neuropsychiatric symptoms

Do social factors impact on biologics costs in rheumatoid arthritis? Results from the Moroccan RBSMR registry Giant cell arteritis treatment patterns and rates of serious infections

The Italian prospective SIRENA study: focus on early psoriatic arthritis cohort and gender differences ABATACEPT IN USUAL AND IN NON-SPECIFIC INTERSTITIAL PNEUMONIA ASSOCIATED TO RHEUMATOID ARTHRITIS. NATIONAL MULTICENTER STUDY OF 190 PATIENTS

Long-term safety and efficacy of upadacitinib in patients with rheumatoid arthritis: 3-year results from the SELECT-EARLY study Predictors of Hospitalisation in Patients with Rheumatic Disease and COVID-19 in Ireland: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

PHYSICAL FUNCTION IN PATIENTS WITH RA, STRATIFIED BY SEROSTATUS AND TREATMENT LINE, FOLLOWING SC ABATACEPT: POST HOC ANALYSIS OF AN OBSERVATIONAL, 2-YEAR STUDY CONDUCTED IN ROUTINE CLINICAL PRACTICE (ASCORE) A retrospective cohort study in Chinese patients with adult polymyositis and dermatomyositis: risk of comorbidities and subclassification using machine learning

The COVID-19 pandemic prompts isolation and behavioral changes in patients with chronic rheumatic diseases leading to reduced physical activity, increased pain, disease activity, and low seroprevalence of SARS-CoV2 antibodies. Real word experience with tofacitinib in patients with rheumatoid arthritis : an interim analysis from a French prospective observational study DeFacTo

DISEASE ACTIVITY IN PATIENTS WITH RA BY SEROSTATUS AND TREATMENT LINE, FOLLOWING TREATMENT WITH ABATACEPT: RESULTS FROM AN INTERNATIONAL OBSERVATIONAL STUDY

The need for information among patients with ANCA associated vasculitis differs between groups.

The therapeutic effects of omega-6 PUFA (Pinolenic acid) on the transcriptomic profile of activated peripheral blood mononuclear cells isolated from healthy controls and Rheumatoid arthritis patients Lupus fog is not dissociative fog MYCOPHENOLATE MOFETIL IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: FIVE-YEARS DRUG SURVIVAL IN RENAL AND NON-RENAL INVOLVEMENT Retroperitoneal fibrosis in Erdheim-Chester disease has unique presenting and prognostic features: a single centre retrospective comparative cohort study EULAR 2021 SCIENTIFIC PROGRAMME

Presentation Session date Session Start Session End Room Name Session Group / Title / Learning objectives Title Start A Prospective, Longitudinal Study to Evaluate Real-World Patient Experiences and Treatment Satisfaction With Secukinumab for Wednesday, 2 June 2021 08:00:00 18:00:00 Posters Viewing (blank) (blank) Psoriatic Arthritis

THE USE OF CANNABIDIOL IN THE TREATMENT OF PAIN RELATED TO SCLERODERMA DIGITAL ULCERS

Discontinuation Rate of Tofacitinib as Monotherapy is Similar Compared to Combination therapy with Methotrexate in Rheumatoid Arthritis Patients: Pooled Data from two Rheumatoid Arthritis Registries in Canada Profile of lumbar spine degenerative pathology in rheumatologic consultation in Northen Togo The prevalence and factors related to sleep apnoea in ankylosing spondylitis

Effects of rituximab in patients with rheumatoid arthritis-related interstitial lung disease: A single-centre experience from Turkey

Risk factors for progression of rheumatoid arthritis-associated interstitial lung disease: reassuring impact of methotrexate Psoriatic arthritis and physical activity, a systematic review Power and spectral Doppler Ultrasound as a screening tool in the diagnostic course of suspected axial spondyloarthritis: preliminary data from a large monocentric cohort.

Subclinical dactylitis: comparative study of therapeutic response with TNF inhibitors, secukinumab and ustekinumab.

Drug survival of biologics with respect to combination with methotrexate in treatment of polyarticular JIA. FRAX and the effect of teriparatide on bone mineral density in secondary osteoporosis Quantifying the Psychosocial Impact of Undifferentiated Connective Tissue Disease (UCTD)

Etanercept-associated new onset uveitis in patients with juvenile idiopathic arthritis under biological therapy: single center experience Long-term outcome of SSc associated ILD: improved survival in PPI treated patients The PsABio study in Italy: a real-world comparison of the persistence, effectiveness and safety of ustekinumab and tumour necrosis factor inhibitors in patients with psoriatic arthritis

Effects of cholecalciferol and calcifediol in osteoporotic women with secondary hyperparathyroidism due to severe vitamin D deficiency undergoing zoledronic acid treatment: a randomized-controlled trial Collagen Turnover Markers are Associated with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase-3 Clinical Trial

13:00:00 14:00:00 Room 1 no session group Opening Plenary session (blank) 13:00:00 Opening by the President of EULAR

14:15:00 15:00:00 Room 1 What is New (WIN) What is new in axial spondyloarthritis? To learn most recent data on diagnosis, classification, outcome assessment, and Introduction treatment of axial spondyloarthritis (including radiographic and non-radiographic forms). 14:15:00 14:20:00 Non-radiographic or radiographic axial SpA – does it matter? 14:50:00 Q&A

15:45:00 Room 10 EULAR Projects What the rheumatologist needs to know to interpret studies in 2021 Methodology of clinical trials and observational studies has changed over time. The phenotype of patients that are studied has also changed over time. In this session, methodological aspects of study design and data analysis will be discussed. Topics like selection bias, propensity scores and ROC-curve analysis will be discussed. 14:15:00 Introduction 14:20:00 Patient profiles in the era of biological treatments - Implications for trial design and interpretation 14:40:00 Q&A 14:45:00 Measurements, composite scores and the art of 'cutting-off' 15:05:00 Q&A 15:10:00 How to improve your propensity score models? 15:30:00 Q&A

15:35:00 Dietary Hyperinsulinemic Potential and Risk of Incident Gout: 3 Prospective Cohort Studies of US Men and Women 15:42:00 Q&A Room 11 Joint, PARE Help! What do I need to cope with my RMD? To present what people with inflammatory diseases should know about managing their disease. To give an overview of various digital solutions for monitoring and coping strategies. 14:15:00 Introduction 14:20:00 What my newly diagnosed patient should know about the disease, its risk factors and comorbidities 14:35:00 Foot problems and foot healthcare for people with RMDs 14:50:00 The influence of physical activity and sports on inflammation 15:05:00 Self-Management 4.0 15:20:00 Debate Room 12 Practical skills New assessments in clinical practice To learn which measures are the best for the heart function in Rheumatic diseases in clinical practice to learn the value of Patient reported outcome measures in Rheumatic Diseases to learn about clinical importance of BASDAI and ASDAS to learn about the added value and clinical importance of composite index measurement of disease activity.